The Pediatric Dermatology Research Alliance (PeDRA) is vibrant research network pursuing the mission to create, inspire, and sustain research to prevent, treat, and cure childhood skin disease.
In this episode of PeDRA Pearls, Jenn Dawson welcomes Delaney Ding, PeDRA’s Research Fellow, to discuss his journey as an MD-PhD student and his work at the intersection of pediatric dermatology, epidemiology, data science, and patient advocacy. Delaney shares insights from his research on skin cancer among people living with HIV, as well as his commitment to patient-centered research, vulnerable populations, and meaningful outcomes. He also discusses the importance of mentorship and collaboration, as well as the unexpected opportunities that can shape a research career. As PeDRA’s inaugural Research Fellow, Delaney shares his vision for advancing research to improve patient outcomes and strengthen the pediatric dermatology community.
This episode is presented by Disc Medicine. Although Disc Medicine provided funding for this PeDRA Pearls Podcast, the contents of the podcast were developed independently by PeDRA. Learn more about Disc Medicine.
In this episode of PeDRA Pearls, Jenn Dawson welcomes back Stefanos Koutsoukos for a deeper conversation about research on rare genetic skin diseases through the lens of both lived experience and bench science. Stefanos shares his family’s diagnostic journey, the evolving terminology surrounding ichthyosis and epidermal differentiation disorders, and how advances in genetics, stem cell models, and patient-reported outcomes are helping shape the future of meaningful therapies. Now a graduate student at the University of Colorado Anschutz, Stefanos is researching rare genetic skin diseases and is a recipient of a 2025 PeDRA Research Fellowship, working under the mentorship of Ganna Bilousova, PhD.
This episode is presented by Disc Medicine. Although Disc Medicine provided funding for this PeDRA Pearls Podcast, the contents of the podcast were developed independently by PeDRA. Learn more about Disc Medicine.
Join Jenn Dawson and Mitchell Hanson for some quick-hitting "research hot takes!"
Topical Therapies Supporting Links and Articles
Social Unrest Leads to Access Barriers Supporting Links and Articles
Skin of Color in Pediatric Dermatology Supporting Links and Articles
This episode is presented by Disc Medicine. Although Disc Medicine provided funding for this PeDRA Pearls Podcast, the contents of the podcast were developed independently by PeDRA. Learn more about Disc Medicine.
In this episode of PeDRA Pearls, Jenn Dawson talks with Colleen Cotton, MD, and Dawn Eichenfield, MD, PhD, leaders of PeDRA’s Acne and Hidradenitis Suppurativa Focus Study Group, about the evolving research landscape for pediatric acne and HS. Together, they discuss the importance of early recognition and referral, patient-centered research, pediatric-specific outcomes, and emerging areas of study, including post-isotretinoin care, stigma, laser hair removal, GLP-1 receptor agonists, hormonal therapies, and gender-affirming care. The conversation highlights how collaboration across clinicians, researchers, patients, and families is helping better shape care for children and adolescents living with chronic inflammatory skin disease.
This episode is presented by Disc Medicine. Although Disc Medicine provided funding for this PeDRA Pearls Podcast, the contents of the podcast were developed independently by PeDRA. Learn more about Disc Medicine.
In this episode of PeDRA Pearls, Heather Gochnauer, MD, joins the podcast to talk about her path into pediatric dermatology, her work at Rady Children’s and UC San Diego, and the clinical and research questions that motivate her early career. This conversation explores continuity of care from childhood into adulthood, Heather’s growing focus on connective tissue disease, and the role of collaboration, mentorship, and curiosity in shaping meaningful research for patients and families.
This episode is presented by Disc Medicine. Although Disc Medicine provided funding for this PeDRA Pearls Podcast, the contents of the podcast were developed independently by PeDRA. Learn more about Disc Medicine
In this episode, Jason Hawkes, MD, returns to discuss the evolving role of translational dermatology in bringing scientific discoveries closer to patient care. He shares how advances in immunology and clinical trials are transforming treatment for psoriasis, atopic dermatitis, hidradenitis suppurativa, urticaria, vitiligo, alopecia areata, and other inflammatory skin diseases. The conversation also explores personalized treatment, whole-person health, access to care through clinical research, and the growing opportunities for pediatric dermatologists to participate in research outside traditional academic settings.
This episode is presented by Disc Medicine. Although Disc Medicine provided funding for this PeDRA Pearls Podcast, the contents of the podcast were developed independently by PeDRA. Learn more about Disc Medicine
In this episode of PeDRA Pearls, we explore the discovery of Bachmann-Bupp syndrome and the remarkable collaboration that transformed a single patient observation into a growing body of research and a promising treatment pathway. Host Jenn Dawson speaks with Caleb Bupp, MD, Andre Bachmann, PhD, and Liz VanSickle, PhD, about the genetics, skin and hair findings, and translational science behind this ultra-rare disorder, as well as the critical role pediatric dermatologists can play in recognizing patients, advancing research, and building connections for families navigating rare disease.
In this episode of PeDRA Pearls, host Jenn Dawson welcomes Mitchell Hanson, MD, MPH, PeDRA’s new Education Fellow, for a conversation about connection, service, and intentionality in pediatric dermatology. Mitchell shares how his path through neuroscience, public health, medical education, and community-centered initiatives led him to PeDRA, and reflects on the importance of keeping patients at the center of research and education. Listeners will hear about his passion for making pediatric dermatology more accessible, the lessons he learned through global health work and SunSafe Augusta, and how setbacks can become meaningful redirections toward purpose.
In the first installment of PeDRA’s 2026 educational series – Research in Action: Advancing Care for Epidermolysis Bullosa (EB), Dr. Peter Marinkovich of Stanford University provides a timely overview of emerging therapies and clinical research in EB, including gene therapies, cell-based approaches, inflammation-targeted treatments, and strategies to improve wound care and long-term outcomes. Dr. Marinkovich includes an excerpt from Aaron Owens, a dystrophic EB patient who participated in a clinical trial. Designed for clinicians, researchers, patients, caregivers, and others involved in EB care, this program highlights recent progress in the field and the collaborative work driving better treatment options for patients.
Click here to view the video version of this webinar.
Special thanks to BioMendics, Castle Creek Biosciences, Chiesi, and Krystal Biotech for their support of the 2026 EB Educational Series. PeDRA is solely responsible for all program content and the selection of all presenters, authors, moderators, and faculty.
Tune in to hear Dr. Cathryn Sibbald and Dr. Ilka Netravali, leaders of PeDRA’s Hair Disorders Focused Study Group, explore how pediatric hair disorders research is evolving beyond alopecia areata. They discuss multicenter studies, emerging biomarkers and precision medicine approaches, cross-specialty collaboration, and the importance of incorporating patient and family perspectives to improve care. The conversation highlights how this growing body of research is helping move the field toward more personalized, evidence-based, and equitable treatment for children with hair disorders.
In this episode, host Jenn Dawson talks with Dr. Dawn Davis, Dr. Amy Paller, and Dr. Larry Eichenfield about the newly published pediatric atopic dermatitis guidelines and what they mean for clinicians, patients, and families. Together, they unpack the evidence behind prevention, comorbidities, and treatment recommendations, discuss how rapidly the therapeutic landscape is evolving, and highlight the biggest unanswered questions that remain in research. The conversation also explores the importance of patient advocacy, shared decision-making, and improving access to care as the field moves toward more personalized treatment.
Guidelines of care for primary prevention of atopic dermatitis and awareness of comorbid conditions in pediatric atopic dermatitis.
Guidelines of care for the management of atopic dermatitis in pediatric patients.
Please click here for a list of speakers' conflicts of interest.
In this episode of PeDRA Pearls, Jenn Dawson is joined by PeDRA Executive Director Mike Siegel and Outcomes Committee Chair Dr. Marcia Hogeling to recap key themes from the Society for Investigative Dermatology (SID) meeting. They discuss emerging trends in dermatology research, including the growing role of genetics, molecular diagnostics, multi-omics, and biologic therapies, as well as highlights from PeDRA’s featured session on vascular anomalies, rare skin diseases, and RIME. The conversation also explores the importance of patient advocacy, collaboration between clinicians and basic scientists, and the exciting future of pediatric dermatology research.
Announcements:
Dr. Megha Tollefson, Department Chair of Dermatology, Professor of Pediatrics and Dermatology at the Mayo Clinic, and PeDRA President-Elect, shares her key takeaways from the PeDRA session at SID.
Meredith Weiss joins the podcast to discuss a study that was presented in the inaugural Gorlin Syndrome Alliance Round Table session at the Society for Investigative Dermatology (SID) meeting. Meredith is the Executive Director for the Gorlin Syndrome Alliance.
Novel PTCH1 Variants in Gorlin Syndrome Identified through Genomic Analysis of 118 Patients. The authors of this study are:
Ryan Kern1, Amy Xiong1, Qianqian Wang2, Philip Beachy2, Jean Tang1*
1Department of Dermatology, Stanford University School of Medicine, Stanford, California, United States; 2Department of Developmental Biology, Stanford University School of Medicine, Stanford, California, United States
Please click here for more information about the Gorlin Syndrome Alliance.
Lynn Petukhova, PhD, is an Assistant Professor in the Ronald O. Perelman Department of Dermatology and the Department of Population Health.
Ganna Bilousova, PhD, is an Associate Professor of Dermatology at the University of Colorado and mentor to Stefanos Koutsoukos, a PhD candidate at the University of Colorado. Dr. Bilousova and Stefanos received a 2025 PeDRA Research Fellowship Award for their project, Characterizing Deficits in Early-Stage Autophagy and Lipid Accumulation in iPSC-Derived Fibroblasts and Keratinocytes from Individuals with Recessive Dystrophic Epidermolysis Bullosa. In this episode, they discuss findings from the study as presented at the Society for Investigative Dermatology (SID) Annual Meeting.
Dr. Chiu joins the podcast to share an update on her ongoing study, Clinical and Genetic Characterization of Recurrent Reactive Infectious Mucocutaneous Eruption (RIME).
Michael Howell, PhD, is an immunologist and the Founder and President of Mountaineer Biosciences.
Dr. Joy Wan is a pediatric dermatologist and an Assistant Professor of Dermatology at Johns Hopkins University School of Medicine.
Dr. Beth Drolet is Professor and Chair, Geneva F. and Sture Johnson Distinguished Chair at the University of Wisconsin, Madison.
Lawrence Eichenfield, MD reflects on the key takeaways from the International Eczema Council meeting at SID.
Dr. El-Feghaly joins the podcast to share her thoughts on the Epidermal Differentiation Disorders meeting as well as the first Gorlin Syndrome Alliance round table!
PeDRA President, Keith Choate, MD, PhD, shares his reflections on the Epidermal Differentiation Disorders Symposium!
Learn more about Epidermal Differentiation Disorders.
Join Jenn for an interview!
PeDRA’s Executive Director, Mike Siegel, PhD, and Director of Educational Programs, Jenn Dawson, are attending the 83rd Annual Society for Investigative Dermatology Meeting in Chicago, IL! In this bonus episode, they highlight what attendees can look forward to and why the SID meeting continues to be such a valuable gathering for the dermatology research community. Stay tuned for ongoing coverage throughout the week, including poster interviews, key takeaways from PeDRA President Keith Choate, MD, PhD, and much more.
Interested in sharing your thoughts about the meeting in a brief interview with Jenn Dawson? Jenn will be on-site through Friday afternoon — reach out here to connect!
In this episode, host Jenn Dawson speaks with Anne Davis, Pys.D., clinical psychologist, grief and trauma specialist, and mother of Hallie Grace Davis, who lived with junctional epidermolysis bullosa (EB). Anne shares Hallie’s story and how her family created Heroes for Hallie Grace to support EB families through memorial and welcome bundles, practical assistance via the Wings of Care Initiative, community events like the Butterfly Ball, and research funding. This conversation offers a clear message for researchers and clinicians alike: center quality of life, listen to patients' and caregivers' experiences, and work together to accelerate progress.
Please click here to learn more about Heroes for Hallie Grace.
Skin reactions during pediatric cancer treatment can be painful, stigmatizing, and sometimes threaten a child’s ability to stay on therapy. In this episode of PeDRA Pearls, Dr. Christina Boull and Dr. Rebecca Levy discuss PeDRA's Skin Tumors and Reactions to Cancer Therapies (STARC) Focused Study Group and its work to prevent, recognize, and manage these toxicities. They highlight multicenter efforts spanning photosensitivity prevention, survivorship outcomes, and targeted therapy side effects—including MEK inhibitor–associated mucocutaneous toxicities—plus the need for stronger derm–onc collaboration, better trial reporting, and evidence-based consensus guidelines.
Click here for more information.
In her final episode as guest host, PeDRA Fellow, Hannah Chang, talks with Dr. Andrea Zaenglein and Dr. Jonette Keri about the 2023 PeDRA consensus recommendations on using combined oral contraceptives and spironolactone for acne in patients ages 9–15. They break down what the guidance says, what to watch for, and how to counsel patients and parents with confidence.
Learn more about this 2023 PeDRA Consensus Project.
In this episode, we bring together two leaders in pediatric dermatology research to explore the work of PeDRA’s Connective Tissue and Autoinflammatory Disorders Focused Study Group. Dr. Kalyani Marathe, who serves as the group’s vice chair, and Dr. Maria Teresa Garcia-Romero, the group’s chair, discuss the importance of collaboration across medical specialties and highlight ongoing studies shaping the future of care for children with autoimmune and autoinflammatory skin conditions. Together, they reflect on the impact of mentorship, patient-centered research, and the evolving landscape of pediatric dermatology.
Click here to learn more!
In this special episode of PeDRA Pearls, host Jenn Dawson speaks with PeDRA Fellow Hannah Chang as she reflects on her two-year fellowship experience. Hannah shares highlights from recent conferences, key lessons from research and mentorship, and insights from her work in pediatric dermatology, education, and health equity. The conversation also looks ahead as Hannah celebrates her dermatology residency match and discusses what excites her most about the next stage of training. This episode offers a thoughtful reflection on growth, community, and the power of mentorship in pediatric dermatology.
Reid Oldenburg, MD, PhD, joins host Jenn Dawson to discuss his journey as a clinician-scientist and his leadership of PeDRA’s Drugs and Bugs Focused Study Group. He shares how early global infectious-disease research shaped his path to dermatology, highlights ongoing projects—from genetic studies to patient-centered resources — and reflects on how collaboration and precision medicine are shaping the future of care.
Drugs & Bugs Focused Study Group
Jenn Dawson and Caitlin Haskell discuss a host of upcoming PeDRA deadlines and opportunities. Here are links to all the items referenced in the episode.
Join PeDRA Fellow Hannah Chang for a roundtable discussion with special guests Dr. Jillian Rork and Dr. Deepti Gupta. Together, they discuss a recent publication titled “Impact of Persistent Alopecia on Quality of Life in Childhood Cancer and Transplant Survivors.” This article was published in Pediatric Blood & Cancer in 2025.
This episode breaks down the foundations of academic clinical research, from how studies are conceived and funded to how protocols ensure rigor, consistency, and patient safety. Listeners learn about the roles of sponsors, CROs, IRBs, and research teams, as well as the advantages and challenges of conducting trials in academic settings.
This independent medical education program is supported by Incyte.
Please click here for a complete list of disclosures.
Episode 2 explores how private‑practice and industry‑run clinical trials bring efficiency, flexibility, and broader patient access to the research landscape. Our guests discuss the financial and scientific motivations behind industry partnerships, the strengths and trade‑offs of private sites, and how these settings support large, fast‑moving studies. Rare‑disease trials, PK designs, and investigator‑initiated research are highlighted as key collaborative touchpoints.
This independent medical education program is supported by Incyte.
Please click here for a complete list of disclosures.
In this final episode, we examine how academia and industry work together to advance research and improve patient outcomes. The conversation highlights real‑world examples of shared data, translational science partnerships, diagnostic insights, and coordinated patient care. Listeners gain a deeper understanding of how combined expertise strengthens clinical trials and expands access to innovative therapies.
This independent medical education program is supported by Incyte.
Click here for a complete list of disclosures.
PeDRA Fellow Hannah Chang hosts a roundtable discussion with Dr. Jillian Rork and Dr. Deepti Gupta about a recent publication titled: Photo Protection in Skin of Color: A Scoping Review of Barriers, Behaviors, and Pediatric Considerations. This article was published in Pediatric Dermatology in September 2025.
Tell us about you by taking this 1-question survey!
PeDRA Fellow Hannah Chang hosts a roundtable discussion with Dr. Jillian Rork and Dr. Deepti Gupta about a recent publication titled: Prevalence and Demographics of Psoriasis in the Down Syndrome Population: A Cross-Sectional Analysis Using the Epic Cosmos Dataset. This article was published in the Journal of the American Academy of Dermatology in September 2025.
Tell us about you by taking this 1-question survey!
In this episode of PeDRA Pearls, we’re joined by Meredith Weiss, Executive Director of the Gorlin Syndrome Alliance (GSA), to explore the intersection of patient advocacy, education, and research. Meredith shares her personal journey into rare disease advocacy and discusses how the GSA supports patients through community-building, clinician-led education, and a growing commitment to funding research–particularly in dermatology. Together, we highlight the critical role patient advocacy organizations play in improving quality of life and advancing meaningful, patient-centered research.
Gorlin Syndrome Alliance RFA
Tell us about yourself!
In this episode of PeDRA Pearls, PeDRA Fellow Hannah Chang speaks with Dr. Milie Fang, a pediatric dermatology fellow at Seattle Children’s Hospital, about her journey into pediatric dermatology. Dr. Fang reflects on how her personal experience with eczema sparked her interest in the field, her evolving research focus, and the mentorship and community she’s found through PeDRA. They also discuss navigating imposter syndrome, building a career in academic medicine, and her hopes for the future of pediatric dermatology.
Tell us about you!
Irene Lara-Corrales, MD is an Associate Professor of Dermatology at the University of Toronto and a pediatric dermatologist at The Hospital for Sick Children (SickKids) in Toronto, Canada. She knew early on that pediatric dermatology was her calling, and her dedication to advancing care for children with complex skin diseases deepened after caring for an infant with epidermolysis bullosa (EB) during her residency in Costa Rica. Most recently, Dr. Lara-Corrales has been a leading champion for hidradenitis suppurativa within PeDRA and across the broader pediatric dermatology research community. Watch or listen to learn more about her professional journey, research passions, and the personal interests that inspire her— including her love of books and tea.
Please note - this interview originally aired in April 2023.
At the time of this interview in 2021, Dr. Carrie Coughlin was an Assistant Professor of Dermatology at Washington University School of Medicine in St. Louis. She was also the Chair of the PeDRA Outcomes Committee, a member of the Meetings and Studies Committees, and led the Skin Tumors and Reactions to Cancer Therapies (STARC) Focused Study Group. Since then, she has become an Associate Professor of Dermatology and is serving as the Treasurer for PeDRA's Board of Directors.
In this episode, Dr. Coughlin shares insights into her work, her leadership within PeDRA, and why effectively communicating pediatric dermatology research beyond the specialty is essential for advancing patient care and collaboration.
Click here to listen to interviews with other PeDRA Board Members.
Lastly, please fill out this anonymous 1-question survey.
Colleen Cotton, MD is a Pediatric Dermatologist and Assistant Professor in the Department of Dermatology at Children’s National Hospital in Washington, DC. Dr. Cotton joined PeDRA as a research fellow in 2013 and was one of the first PeDRA Fellows. She now serves on PeDRA's Early Investigator and Meetings Committees, as well as a participant in PeDRA’s Mentorship Program as both a mentor and mentee. Be sure to watch to the end to learn more about Dr. Cotton’s unique hidden talent.
This episode originally aired in September 2022. Since then, Dr. Cotton has now taken over as Chair of the Early Investigator Committee and has joined PeDRA's Board of Directors.
This is part three—and the final installment—of our series on complementary and alternative medicine in pediatric dermatology. In this episode, we turn our focus to the future, examining key research gaps, promising areas for investigation, and opportunities for collaboration. Dr. Peter Lio and Dr. Larry Eichenfield share their perspectives on where integrative approaches may intersect with advancing science, and how curiosity, rigor, and innovation can help move the field forward.
Special thanks to Incyte for supporting this independent medical education program.
Tell us about yourself by filling out this 1-question survey.
This is part two of our conversation on complementary and alternative medicine in pediatric dermatology. While these approaches may offer benefits, they can also carry risks—especially when misinformation spreads quickly online. In this episode, Dr. Peter Lio and Dr. Larry Eichenfield explore how pediatric dermatologists can assess safety, address popular but unproven therapies, and support families in making informed decisions, all while maintaining strong, trusting clinical relationships.
Special thanks to Incyte for supporting this independent education program.
Tell us about yourself by filling out this 1-question survey.
In today’s episode, we’re diving into a topic that’s increasingly shaping conversations in pediatric dermatology clinics: complementary and alternative therapies. Families are asking about everything from dietary changes to topical botanicals—and clinicians are navigating how to respond with empathy, evidence, and safety in mind. Joined by Dr. Peter Lio and Dr. Larry Eichenfield, we’ll explore why interest in these therapies is growing, which approaches families are using most, and how pediatric dermatologists can engage in these conversations thoughtfully and effectively.
Thank you to Incyte for supporting this independent medical education program.
Tell us about yourself by filling out this 1-question survey.
In this special 2025 Year in Review episode of PeDRA Pearls, host Jenn Dawson is joined by PeDRA Executive Director Mike Siegel for a wide-ranging and reflective conversation on the year behind—and what lies ahead for pediatric dermatology research. Together, they explore how the PeDRA community navigated uncertainty in the broader research landscape while continuing to make meaningful progress across collaborative research, funding, education, events, and patient engagement.
Tell us about yourself by filling out this ONE-question survey.
Donate today.
In this episode, Dr. Pope shares her journey into pediatric dermatology, the surprising role mentorship played in shaping her academic career, and how her clinical passions grew into a rich and varied research portfolio spanning rare diseases, clinical trials, guidelines, and collaborative multicenter work. We also dive into her vision for PeDRA’s future, the evolving landscape of research, and the tools she believes will empower the next generation of investigators.
Sherry Baluch brings a unique blend of clinical and technical experience to PeDRA. She attended medical school before earning a Master’s in Computer Science and transitioning into healthcare technology. In a previous role as a Technical Project Manager, she led strategic modernization initiatives to improve lab operations and data systems. Sherry is passionate about supporting PeDRA’s mission to advance collaborative research that improves the lives of children with skin disease.
In this episode, nurse practitioner Nichole Halliburton from Cincinnati Children’s Hospital shares practical, real-world guidance on managing epidermolysis bullosa (EB). She breaks down EB subtypes, key stages of wound healing, and everyday challenges patients and caregivers face. Nichole offers actionable strategies for bathing, blister care, dressing changes, and the use of birch triterpenes in wound management. She also highlights the emotional and logistical burden of EB and the importance of support, education, and individualized care. This conversation is a helpful resource for clinicians, caregivers, and anyone involved in EB care.
This podcast is being hosted by PeDRA and sponsored by Chiesi. PeDRA will evaluate content for suitability for its audience, but is not responsible for creating content, selecting speakers, or delivering presentations.
Learn more about Nichole Halliburton, MSN, APRN-CNP
In this episode of PeDRA Pearls, we sit down with Dr. Marcia Hogeling, Associate Professor of Dermatology and Residency Program Director at UCLA. Dr. Hogeling shares her inspiring journey from pediatrics to pediatric dermatology, reflecting on the mentors who shaped her career and the importance of guiding the next generation of clinicians and researchers. She also discusses her diverse research interests—from vascular birthmarks to inflammatory skin diseases—and offers an inside look at her new role as Chair of PeDRA’s Outcomes Committee. Tune in to learn how Dr. Hogeling and her colleagues are measuring impact, fostering collaboration, and advancing the field of pediatric dermatology—all while keeping a love for mentorship, research, and even skiing at the heart of her work.
Update your profile and renew your membership today!
In this third and final episode, we're diving deep into how emerging insights about the microbiome are shaping the way clinicians counsel families and care for pediatric patients. Dr. Shoch and Dr. Castelo-Soccio share how understanding the microbiome has changed their clinical practice, from their approach to bathing routines and yeast overgrowth to dietary counseling and the cautious use of probiotics and bleach baths. Together, they explore what we know and what we don't, and where the future of microbiome research in pediatric dermatology might be headed.
In this second episode, we discuss how infant microbiomes develop and what factors shape them, and how early life disruptions may increase the risk of disease. The conversation also touches on the hygiene and biodiversity hypothesis, the role of dysbiosis in conditions like atopic dermatitis, and the ongoing challenge of teasing apart whether microbiome shifts are causes or markers of disease.
Special thanks to Incyte for supporting this independent medical education program.
The PeDRA Annual Conference is just days away, and excitement is building! In this special episode of PeDRA Pearls, host Jenn Dawson sits down with Executive Director Mike Siegel, PhD to talk about what attendees can expect in Minneapolis. From this year’s theme of building consensus to advance pediatric dermatology research to highlights like Focused Study Groups, the NextGen Research Forum, the Early Investigator Reception, Camp Wonder, and the Dash for Discovery, Mike shares what makes this gathering so unique. Whether you’re joining us in person or tuning in from afar, get a behind-the-scenes look at the people, partnerships, and energy that make the PeDRA Conference a one-of-a-kind event.
In this episode of PeDRA Pearls, host Hannah Chang sits down with Dr. Lisa Arkin, Associate Professor of Dermatology and Director of Pediatric Dermatology at the University of Wisconsin–Madison. They discuss the unique opportunities offered through UW’s pediatric dermatology fellowship, the importance of customizable training experiences, and the evolving research landscape in areas such as autoinflammatory disease and vascular anomalies. Dr. Arkin also reflects on lessons learned through challenges in research, the value of mentorship, and advice for trainees and early investigators entering the field.
In this episode, we explore the intersection of storytelling and science. Join us as we dive into Eva’s Itchy Adventure, a children’s book created to help kids living with eczema better understand and manage their condition. We’ll discuss the concept of bibliotherapy—using books as a therapeutic tool—and how it can improve outcomes by reducing anxiety, empowering patients, and strengthening connections between families and healthcare providers.
Books referenced in this episode:
Updates:
In episode 21, PeDRA Pub Club host Hannah Chang and guest panelists, Dawn Eichenfield, MD, PhD, and Jinia El-Feghaly, MD, discuss the article "An international multicenter, retrospective cohort study of 203 patients with pediatric androgenetic alopecia“published in Journal of the American Academy of Dermatology in 2025.
Updates:
In episode twenty, PeDRA Pub Club host Hannah Chang and guest panelists, Dawn Eichenfield, MD, PhD, and Jinia El-Feghaly, MD discuss the article The Association of Psoriasis and Bacterial Infections in Pediatric Patients: A Retrospective Review, published in Pediatric Dermatology in 2025.
PeDRA Annual Conference
In episode nineteen, PeDRA Pub Club host Hannah Chang and guest panelists, Dawn Eichenfield, MD, PhD, and Jinia El-Feghaly, MD discuss the article Survey Access to and Use of Narrowband UVB Phototherapy in Pediatric Vitiligo, published in Pediatric Dermatology in 2025.
PeDRA Annual Conference
Dash for Discovery
In this heartfelt episode of PeDRA Pearls, we shine a spotlight on congenital melanocytic nevi (CMN)—a rare and often misunderstood skin condition present at birth. Tune in to hear Maggie, a physician and mother whose son Reid was born with a giant CMN, and Dr. Harper Price, Division Chief of Pediatric Dermatology at Phoenix Children’s Hospital, as they explore the emotional journey from diagnosis to advocacy, the medical complexities of CMN, and the urgent need for accurate information and coordinated care. You'll also learn about the groundbreaking Nevus Owners Outcomes Registry (NOOR), a collaborative effort between Nevus Outreach and PeDRA that’s paving the way for patient-centered research and improved outcomes for families everywhere.
In this heartwarming episode of PeDRA Pearls, we take a break from our usual research-focused content to spotlight the power of community, creativity, and confidence-building for children with skin conditions. Host Jenn Dawson is joined by Dr. Alanna Bree, founder of Made a Masterpiece, and medical student Alisha Kashyap to discuss their co-authored children’s book Loving the Skin You’re In at Camp Dermadillo. Tune in to learn about the inspiration behind the book, the transformative experience of dermatology camps like Camp Dermadillo and Camp Discovery, and the growing impact of Made a Masterpiece on families across the country.
In our final episode focused on the OX40 pathway and its emerging therapies, Dr. Joy Wan moderates a thoughtful discussion with two leaders from the patient advocacy community. Wendy Smith Begolka, MBS, Chief Program and Mission Officer at the National Eczema Association, and Korey Capozza, MPH, Founder and Executive Director of Global Parents for Eczema Research, share their perspectives on incorporating patient priorities into clinical trials and effectively communicating with patients about new and emerging treatments.
Disclosures:
Joy Wan, MD - Sun Pharmaceuticals – consulting (DMC), Astria Therapeutics – consulting (ad board), Galderma – fellowship funding (paid to Johns Hopkins)
Wendy Smith-Begolka, MBS - Amgen/Kyowa, Kirin, Pfizer, Sanofi – advisory board honoraria; Arcutis, Incyte, Galderma – speaker fees; Pfizer, Sanofi – research grants
Korey Capozza, MPH - Advisory board honoraria from Amgen, Kyowa Kirin, Incyte, and Pfizer
In episode eighteen, PeDRA Pub Club host Hannah Chang and guest panelists, Bella Plumptre, MBBS, and Cheryl Bayart, MD, discuss the article How issues of autonomy and consent differ between children and adults: Kids are not just little people, published in Clinical Dermatology in 2017.
PeDRA and the greater pediatric dermatology community are deeply saddened by the sudden passing of Dr. Robert Sidbury. To donate in his honor, please visit the SPD Foundation.
Welcome to today’s episode of the PeDRA Pearls Podcast! In this installment, Dr. Colleen Cotton is joined by medical student Mana Nasseri to discuss their research project titled "Impact of Bariatric Surgery on Pediatric Hidradenitis Suppurativa." Tune in as they share what inspired this important work, key insights from their findings, and the questions that still remain. Whether you're a clinician, researcher, or simply curious about the intersection of dermatology and pediatric obesity, this episode is full of valuable perspectives you won’t want to miss.
Updates:
In episode seventeen, PeDRA Pub Club host Hannah Chang and guest panelists, Bella Plumptre, MD, and Cheryl Bayart, MD, discuss a recent PeDRA publication, Dermatologic Conditions in Down Syndrome: A Multi-Site Retrospective Review of International Classification of Diseases published in Pediatric Dermatology in 2024.
PeDRA Awards Program
PeDRA Annual Conference
Following the June 23 OX40 webinar, Dr. Eichenfield, Dr. Simpson, and Dr. Wan continue the conversation with a look ahead at the future of OX40 therapies and their potential to change the course of disease. They also unpack the complex concept of remission in atopic dermatitis—what it means, how it's defined, and whether it's truly achievable.
To watch the OX40 webinar, please click here.
Disclosures:
Lawrence Eichenfield, MD has served as a consultant, speaker, advisory board member, or investigator for AbbVie, Acrotech, Almirall, Amgen, Apogee, Arcutis, Attovia, Bristol Myers Squibb, Castle Biosciences, CorEvitas, Dermavant, Eli Lilly, Forte, Galderma, Incyte Corporation, Janssen, Johnson & Johnson, LEO Pharma, Novartis, Ortho Dermatologics, Pfizer, Regeneron, Sanofi Genzyme, Target RWE, T-Rex, and UCB.
Eric Simpson, MD reports personal fees from AbbVie, Aclaris Therapeutics, Amgen, Arcutis, Astria Therapeutics, Attovia Therapeutics, Inc., Bambusa Therapeutics Inc., Castle, CorEvitas, Dermira, Eli Lilly, Evomunne, FIDE, Impetus Healthcare, Incyte, Innovaderm Reche/ Indero, Inmagene Biopharmaceuticals, Janssen, LectureLinx (LLX), Leo, NUMAB Therapeutics AG, Pfizer, Recludix Pharma, Regeneron, Roche Products Ltd, Sanofi-Genzyme, SITRYX Therapeutics
Eric Simpson, MD reports grants (or serves as Principal investigator role) for AbbVie, Acrotech, Amgen, Arcutis, ASLAN, Castle, Dermavant, CorEvitas, Dermira, Eli Lilly, Incyte, Pfizer, Regeneron, Sanofi-Genzyme, Target, VeriSkin
Joy Wan, MD Sun Pharmaceuticals - consulting (DMC), Astria Therapeutics - consulting (ad board), Galderma - fellowship funding (paid to Johns Hopkins)
This engaging and informative webinar explores the role of OX40 and OX40L in pediatric dermatology. OX40: Innovative Insights and Therapeutic Potential in Pediatric Dermatology brings together experts in the field to discuss emerging research, mechanisms of action, and the implications of targeting the OX40 pathway for treating chronic inflammatory skin diseases in children. To view the video version of this webinar, please click here.
Disclosures:
Lawrence Eichenfield, MD has served as a consultant, speaker, advisory board member, or investigator for AbbVie, Acrotech, Almirall, Amgen, Apogee, Arcutis, Attovia, Bristol Myers Squibb, Castle Biosciences, CorEvitas, Dermavant, Eli Lilly, Forte, Galderma, Incyte Corporation, Janssen, Johnson & Johnson, LEO Pharma, Novartis, Ortho Dermatologics, Pfizer, Regeneron, Sanofi Genzyme, Target RWE, T-Rex, and UCB.
Eric Simpson, MD reports personal fees from AbbVie, Aclaris Therapeutics, Amgen, Arcutis, Astria Therapeutics, Attovia Therapeutics, Inc., Bambusa Therapeutics Inc., Castle, CorEvitas, Dermira, Eli Lilly, Evomunne, FIDE, Impetus Healthcare, Incyte, Innovaderm Reche/ Indero, Inmagene Biopharmaceuticals, Janssen, LectureLinx (LLX), Leo, NUMAB Therapeutics AG, Pfizer, Recludix Pharma, Regeneron, Roche Products Ltd, Sanofi-Genzyme, SITRYX Therapeutics
Eric Simpson, MD reports grants (or serves as Principal investigator role) for AbbVie, Acrotech, Amgen, Arcutis, ASLAN, Castle, Dermavant, CorEvitas, Dermira, Eli Lilly, Incyte, Pfizer, Regeneron, Sanofi-Genzyme, Target, VeriSkin
Joy Wan, MD Sun Pharmaceuticals - consulting (DMC), Astria Therapeutics - consulting (ad board), Galderma - fellowship funding (paid to Johns Hopkins)
In this episode of PeDRA Pearls, we host a powerful conversation featuring the Gorlin Syndrome Alliance (GSA). Join us as we delve into the world of Gorlin Syndrome through the heartfelt narrative of Taylor Hodge, who recounts her family's journey following her son's diagnosis at just 18 months old. Joined by Dr. Elena Hawryluk of Harvard Medical School, the discussion sheds light on current research gaps and future directions in the field. Meredith Weiss, Executive Director of the GSA, also contributes, highlighting the essential patient support programs offered by the GSA and the organization's unwavering commitment to research and collaboration. This episode offers a blend of personal insight and professional expertise, providing listeners with a comprehensive understanding of Gorlin Syndrome and the ongoing collaborative efforts to support those affected.
In episode sixteen, Hannah Chang is joined by Dr. Bella Plumptre and Dr. Cheryl Bayart to discuss the article Interobserver and Intraobserver Agreement on the Treatment of Infantile Hemangiomas published in JAMA Dermatology in 2025.
Join PeDRA Executive Director Mike Siegel, PhD, and Pediatric Dermatologist Dr. Carrie Coughlin, Chair of PeDRA’s Outcomes Committee, as they wrap up our coverage of the Society for Investigative Dermatology (SID) meeting. In this final recap, they highlight key moments from the PeDRA session and discuss why SID is a vital event for anyone involved in pediatric dermatology research. Tune in for insights, takeaways, and a look ahead!
Human genetics researcher Lynn Petukhova shares her thoughts on SID, and what's getting her excited about hidradenitis suppurativa genetics research.
Additional coverage of the 2025 Society for Investigative Dermatology meeting with Dr. Joy Wan.
Tune in for interviews with Keith Choate, MD, PhD of Yale University, Joyce Teng, MD, PhD of Stanford University, Emily Gorell, DO of the University of Colorado, and Cristy Garza Mayers, MD, PhD of the University of Washington.
Watch the podcast feed for bonus episodes in June!
Tune in for poster presentations from Rebecca Urbonas of Florida Atlantic University, Ryland Mortlock of Yale University, and Alexa Deregnaucourt of the University of Cincinnati.
Tune in for interviews with Michael Howell, PhD, Founder of Moutaineer Biosciences, and a member of the SID Committee for Scientific Programs.
The second interview is a wonderful discussion with HS Foundation Brent Hazelett, CEO, and Director of Education Lauren Klinedinst.
Learn more about the HS Foundation.
PeDRA/HS Foundation Challenge Grant.
Welcome to Day One coverage of the Society for Investigative Dermatology Meeting! This interview includes a welcome from our executive director, Mike Siegel, an early poster review from graduate student Amanda Orosco, and an overview of the International Eczema Council meeting with Dr. Lawrence Eichenfield. Stay tuned for more exciting coverage! If you'd like to join us for an interview, please stop by the PeDRA booth or email Jenn Dawson!
In episode fifteen, PeDRA Pub Club host Hannah Chang and guest panelists Kalyani Marathe, MD, Cristy Garza-Mayers, MD, PhD, and Allison Miller, MD, discuss a recent PeDRA publication, Comparison of the Skindex-Teen and the Skindex-29 Quality of Life Survey Instruments in a Predominantly American Indian Adolescent Population, published in Pediatric Dermatology in 2024.
Whether you’re a longtime pediatric dermatologist, currently in training, or a patient or advocate who wants to learn more about the latest research in pediatric dermatology, this podcast is for you. Through a structured roundtable discussion, listeners will gain valuable insight into publications relating to pediatric dermatology and understand what this research means for both patients and providers.
PeDRA is thrilled to announce that Eunice Bolay is stepping into a new Membership and Operations Coordinator role! In this new role, Eunice will manage our member database, support day-to-day operations, and serve as a key resource for current and prospective members. Please join us in congratulating Eunice on her new role and listen to learn about her background and aspirations for the future!
The 2025 Spring Mentorship Mingle offers valuable insights into preparing for a dermatology residency application. PeDRA mentors discuss key strategies for crafting a standout application, with a focus on the essential role of research in setting yourself apart from other candidates.
In episode fourteen, PeDRA Pub Club host Hannah Chang, and guest panelists, Kalyani Marathe, MD, Cristy Garza-Mayers, MD, PhD, and Allison Miller, MD discuss a recent PeDRA publication, Transition of Care in Adolescents with Epidermolysis Bullosa: The Provider Perspective published in Pediatric Dermatology in 2024.
Whether you’re a longtime pediatric dermatologist, currently in training, or a patient or advocate who wants to learn more about the latest research in pediatric dermatology, this podcast is for you. Through a structured roundtable discussion, listeners will gain valuable insight into publications relating to pediatric dermatology and understand what this research means for both patients and providers.
This new PeDRA webinar dives into the latest advancements in TYK2 (Tyrosine Kinase 2) research, examining its potential role in the treatment of various pediatric dermatological conditions. Expert, Johann Gudjonsson, MD, PhD discusses the emerging therapeutic strategies targeting TYK2, their clinical applications, and the future direction of pediatric dermatology treatments. Kelly Cordoro, MD moderates this excellent program. View the video presentation here.
Join us for an insightful conversation with Dr Philippa Charlton, Senior Development Physician at UCB, on the latest episode of PeDRA Conversations with Collaborators. Dr Charlton shares her journey from academia to industry, where she now leads UCB’s clinical pediatric development program in immunology. With a rich background as a pediatric geneticist, endocrinologist, and epidemiologist, she offers a unique perspective on advancing drug development to improve patient care.
In episode thirteen, PeDRA Pub Club host Hannah Chang, and guest panelists, Kalyani Marathe, MD, Cristy Garza-Mayers, MD, PhD, and Allison Miller, MD discuss a recent PeDRA publication, Elucidating Disparities in Sunscreen Coverage Among State Medicaid Preferred Drug Lists published in Pediatric Dermatology in 2024.
Whether you’re a longtime pediatric dermatologist, currently in training, or a patient or advocate who wants to learn more about the latest research in pediatric dermatology, this podcast is for you. Through a structured roundtable discussion, listeners will gain valuable insight into publications relating to pediatric dermatology and understand what this research means for both patients and providers.
Season five kicks off with an interview featuring JiaDe (Jeff) Yu, MD—a pediatric dermatologist at Massachusetts General Hospital specializing in allergic contact dermatitis. Dr. Yu’s journey with PeDRA began as a resident, and he now plays a vital leadership role as Co-Chair of the Meetings Committee and a member of the PeDRA Board of Directors. Tune in to hear about Dr. Yu's research success, insights into the 2025 PeDRA Annual Conference, and his ambitious goal of running a marathon in every state and continent.
In episode twelve, PeDRA Pub Club host Hannah Chang, and guest panelists, Leah Lalor, MD, and Kristi Derrick, MD discuss a recent PeDRA publication, Online, home-based dystrophic epidermolysis bullosa registry, published in Pediatric Dermatology in 2024.
In episode eleven, PeDRA Pub Club host Hannah Chang, and guest panelists, Leah Lalor, MD, and Kristi Derrick, MD discuss a recent PeDRA publication, Geomapping of Pediatric Dermatologists: A Tool to Promote Diversity and Equity in Dermatology, published in Pediatric Dermatology in 2024. To view these maps, click here. To request an update or change to this map, please email PeDRA's Associate Director of Education Programs, Jenn Daswon.
Join Mike Siegel, PeDRA's Executive Director as he gets to know PeDRA's new president, Dr. Keith Choate. Dr. Choate is the Aaron B. and Marguerite Lerner Professor and Chair of Dermatology. Professor of Genetics and Pathology, and Associate Dean for Physician-Scientist Development at Yale School of Medicine. Learn more about his journey to becoming a physician-scientist, what inspires him, and his vision for PeDRA.
Join Dr. Albert Yan as he moderates a three-part Points of Discussion about the pros and pitfalls of artificial intelligence as a research tool. In episode one, the group defines artificial intelligence and gives specific examples of how a clinician or researcher might use it.
In part two of the PeDRA Points of Discussion, the group discusses the challenges around populating AI with meaningful data and how AI is augmenting the training landscape.
In the final installment of this Points of Discussion, the group shares their personal stories when it comes to the benefits of AI in dermatology, and talks about the overall benefit of AI as a research tool.
In episode ten of Getting to Know Your Research, Dr. Rebecca Levy discusses her 2021 William Weston Career Development Award to Characterize the Cutaneous Late Effects in Pediatric Hematopoietic Stem Cell Transplantation Recipients.In collaboration with the Hematopoietic Stem Cell Transplantation (HSTC) Late Effects Clinic at the Hospital for Sick Children in Toronto, Canada, this project aims to analyze data from linked provincial databases to define the risks and predictions of skin cancers in individuals who underwent HSCT. Listen to learn more about her findings and what this means for patients.
In episode ten, PeDRA Pub Club host Hannah Chang, and guest panelists, Leah Lalor, MD, and Kristi Derrick, MD discuss a recent PeDRA publication, A Survey Assessment of Combined Pediatric Dermatology-Rheumatology Clinics published in Pediatric Dermatology in 2024.
In episode nine, Dr. Erin Mathes and Dr. Mitchell Braun discuss their PeDRA 2021 Research Fellowship Award titled Long Term Outcomes and Quality of Life in PHACE Syndrome. Listen to learn more about their partnership and the things that surprised them about this project!
Tune in for a delightful and informative conversation about the burden and stigma surrounding pediatric hyperhidrosis. Executive Director and Founding Member Lisa Pieretti eloquently highlights the gaps in pediatric hyperhidrosis research and the importance of education and awareness. In the second interview, watch an entire family share how they cope with hyperhidrosis and their hopes for future research. Learn more at www.sweathelp.org.
In episode nine, PeDRA Pub Club host Hannah Chang, and guest panelists, Holly Neale, MD, and Emily Croce, PhD, APRN, CPNP-PC discuss a recent PeDRA publication, Dupilumab Improves Clinical Scores in Children and Adolescents with Moderate to Severe Atopic Dermatitis: A Real-World Single-Center Study published in The Journal of Allergy and Clinical Immunology Pediatric Dermatology in 2022.
It's your Monday update on a Tuesday!
In episode eight of Getting to Know Your Research, Dr. Wenelia Baghoomian discusses her 2021 PeDRA Research Fellowship project titled The Impact of Topical Prescription Drug Delivery Devices in the Adherence and Ease of Use of Corticosteroids in Pediatric Patients with Atopic Dermatitis. Listen to learn about the inspiration for this project and the partnerships that made it successful.
Consensus Grant Q&A
November 1: Deadline to submit applications for SOCS Mentorship and the Observership Grant Programs
November 1-3: 9th Annual Symposium on Hidradenitis Suppurativa Advances in Austin, TX
November 7: Deadline to submit applications for SPD Pediatric Dermatology Fellowship Matching Program
December 1: Deadline to submit applications for Sanofi and Regeneron Diversity, Equity and Inclusion Mid-Career Award
December 5: Deadline to submit SPDCase Submission of the Year
December 6-8: 2024 HS Academy in Irving, TX
October is Eczema Awareness Month - Nationa Eczema Association
It's your Monday Update on Tuesday! Below are some important links!
In episode eight, PeDRA Pub Club host Hannah Chang, and guest panelists, Holly Neale, MD, and Emily Croce, PhD, APRN, CPNP-PC discuss a recent PeDRA publication, Dermatology Life Quality Index Survey in Patients with Down Syndrome and Caregivers published in Pediatric Dermatology in 2024. Whether you’re a longtime pediatric dermatologist, currently in training, or a patient or advocate who wants to learn more about the latest research in pediatric dermatology this podcast is for you. Through a structured roundtable discussion, listeners will gain valuable insight into publications relating to pediatric dermatology and understand what this research means for both patients and providers.
In this final episode about the proposed pediatric dermatology residency track, the group discusses the measurable outcomes for the program, as well as the expected impact the new track will have on pediatric dermatology research.
In episode two the group discusses the details about the proposal, as well as who this proposal was crafted.
PeDRA's Education Focused Study Group presents a three-part series on the newly proposed pediatric dermatology residency track. Join moderator Leah Lalor, MD, along with guests Esteban Fernandez Faith, MD, Ilona Frieden, MD, and Joy Mosser, MD, as they explore the current state of the pediatric dermatology workforce, the history of pediatric dermatology training programs, details of the proposed residency track, and how its implementation could enhance pediatric dermatology research.
In episode one the group discusses the current state of the pediatric dermatology workforce and the history of the pediatric dermatology training program.
In episode three of Unraveling HS, Brindley Brooks, Founder and Executive Director of HS Connect, and Dr. Ginette Okoye, Professor of Dermatology at Howard University, discuss the future of research and the importance of integrating the patient voice in research and clinical trials.
Please click here to learn more about the resources HS Connect can offer patients and caregivers. The HS Foundation is hosting its annual Symposium on Hidradenitis Suppartiva Advances in Dallas, TX November 1-3, to learn more click here. To access additional HS educational resources PeDRA offers, please click here.
The weekly update is here:
PeDRA Annual Conference Registration - October 24-26, Phoenix, AZ
Dash for Discovery Fun Run
Consensus Grant Q&A
Unraveling HS Podcast
Welcome to the PeDRA Monday update! This is a quick way to get caught up on all the exciting things happening within PeDRA that you might have missed! Links referenced in this recording are as follows:
PeDRA Conference Registration
Consensus Grant Program and Q&A Sign-Up
Conversations with Collaborators Podcast
Dash for Discovery Fun Run
In this interview, PeDRA and Sanofi discuss how they are working together to advance pediatric dermatology research, combining their expertise and resources to drive innovation and improve care for children affected by skin diseases. Through this collaboration, they aim to support groundbreaking studies, foster new treatments, and provide greater opportunities for researchers to address unmet needs in pediatric dermatology.
Please follow these links to access the website resources shared in this interview. For clinical trials and medical information for investigators, please click here. ORIGINS grant program, please click here. For patient and caregiver information, please click here.
This interview includes information on a therapy currently under clinical investigation. Thus, no conclusions on its efficacy and safety can be drawn.
In episode seven, PeDRA Pub Club host Hannah Chang, and guest panelists, Holly Neale, MD, and Emily Croce, PhD, APRN, CPNP-PC discuss a recent PeDRA publication, Trends in Health Care Utilization Among United States Children With Eczema by Age, Sex, Race, and Hispanic Ethnicity: National Health Interview Survey 2006-2018 published in Pediatric Dermatology in 2023.
We're thrilled to kick off our inaugural episode with Dr. Chudy Nduaka, the Therapeutic Area Head of Dermatology at AbbVie's U.S. Medical Affairs. Dr. Nduaka's journey into medicine was inspired by his childhood in Nigeria, driving his passion to develop therapies for those in need. Tune in to hear about his remarkable work and discover the exciting opportunities for PeDRA investigators to collaborate with AbbVie.
In episode seven of Getting to Know Your Research, Dr. Dawn Eichenfield and Dr. Jennifer Sui discuss their 2022 PeDRA Research Fellowship project titled Characterization of non-coding genetic loci and transcription factors that drive the development of linear morphea. Listen to learn about the many collaborations needed to propel a study like this.
In episode six, PeDRA Pub Club host Donglin Zhang, MD, and guest panelists, Stephen Humphrey, MD, Mary Larijani, MD, and Milie Fang, DO, discuss a recent PeDRA publication, Presenting Characteristics and Progression of Pediatric On-Set Morphea published in Pediatric Dermatology in 2023. Whether you’re a longtime pediatric dermatologist, currently in training, or a patient or advocate who wants to learn more about the latest research in pediatric dermatology this podcast is for you. Through a structured roundtable discussion, listeners will gain valuable insight into publications relating to pediatric dermatology and understand what this research means for both patients and providers.
Episode Three: Non-Prescriptions and Just Over the Horizon
Drs. Yu, Wan, and Lio team up for one final discussion about upcoming therapies and research gaps.
Please click here for a list of guest disclosures.
Episode Two: Non-Steroidal Alternatives. From TCIs to PDE4i and JAKis, the Acronyms Rage On.
The team is back to discuss non-steroidal medications for inflammatory skin disease in children.
Please click here for a list of guest disclosures.
Episode One: Topical Steroids - The Double-Edged Sword
Join JiaDe (Jeff) Yu, MD, MS as he hosts a spirited discussion with Joy Wan, MD, and Peter Lio, MD about using topical steroids to treat skin disease in children.
Please click here for a list of guest disclosures.
PeDRA is thrilled to welcome our new 2024-2025 PeDRA Fellow, Hannah Chang! Hannah is a third-year medical student at the University of Texas, Southwestern. As the PeDRA Fellow, she will support PeDRA educational initiatives and the PeDRA Board of Directors and looks forward to playing a key role in the upcoming PeDRA Annual Conference. Listen to Hannah’s inspiring journey from studying economics at the University of Pennsylvania to pursuing medical school and pediatric dermatology research. Plus, discover her many hidden talents along the way!
In episode three, the group discusses the challenges around researching this topic, and what kind of studies are still needed to address this question.
Disclosures:
Lisa Arkin, MD - no relevant disclosures
Lawrence Eichenfield, MD - no relevant disclosures
Denise Metry, MD - Receives author royalties for three hemangioma chapters in UpToDate
Maria G. Buethe, MD - no relevant disclosures
In episode two, Dr. Lawrence Eichenfield discusses the reasons laser therapy isn't used more often and the benefits of propranolol.
Disclosures:
Lisa Arkin, MD - no relevant disclosures
Lawrence Eichenfield, MD - no relevant disclosures
Denise Metry, MD - Receives author royalties for three hemangioma chapters in UpToDate
Maria G. Buethe, MD - no relevant disclosures
In the first episode of this three-part series, Dr. Denise Metry provides an overview of infantile hemangiomas and Dr. Arkin discusses the benefits of laser therapy.
Disclosures:
Lisa Arkin, MD - no relevant disclosures
Lawrence Eichenfield, MD - no relevant disclosures
Denise Metry, MD - Receives author royalties for three hemangioma chapters in UpToDate
Maria G. Buethe, MD - no relevant disclosures
Andrea Zaenglein, MD, and colleagues Sarah Horvath, MD, and Sara Gold, MD provide important information about how and why to counsel patients taking isotretinoin on the use of emergency contraception. This podcast reviews data gleaned from a 2022 PeDRA survey about the comfort level of pediatric dermatologists counseling patients taking isotretinoin about emergency contraception and the counseling and provision practices of those pediatric dermatologists. Listen to learn more. Click here to read the recent article Emergency Contraception for Patients Taking Isotretinoin published in JAMA Dermatology. For the survey results publication, please click here. Listeners can also learn more about the iPledge program by listening to a 2021 PeDRA Points of Discussion Podcast: Is iPledge Working? A Conversation on Isotretinoin.
In episode five, PeDRA Pub Club host Donglin Zhang, MD, and guest panelists, Stephen Humphrey, MD, Mary Larijani, MD, and Milie Fang, DO, discuss a recent PeDRA publication, Efficacy of a lay community health worker (promotoras de salud) program to improve adherence to emollients in Spanish-speaking Latin American pediatric patients in the United States with atopic dermatitis: A randomized, controlled, evaluator-blinded study. This study was published in Pediatric Dermatology in 2022. Whether you’re a longtime pediatric dermatologist, currently in training, or a patient or advocate who wants to learn more about the latest research in pediatric dermatology this podcast is for you. Through a structured roundtable discussion, listeners will gain valuable insight into publications relating to pediatric dermatology and understand what this research means for both patients and providers.
We’re thrilled to bring you a brand-new episode of Community Spotlight, highlighting the vibrant Dermatology Nurses Association (DNA). This remarkable organization supports dermatology nurses and nurse practitioners through a robust educational program and shares an inspiring origin story similar to PeDRA’s own humble beginnings.
Dermatology nurses are essential in the research community, making critical observations on the front lines of patient care that often lead to significant research projects. To honor and recognize the invaluable role nurses play in organizations like PeDRA, we're excited to offer a special PeDRA membership rate for DNA members now through July 31, 2024. Becoming a member of PeDRA opens doors to collaboration and participation in groundbreaking research. Connect with clinicians, investigators, patients, families, advocates, and partners with a shared vision of changing lives and healing children with skin disease through collaboration and discovery. Plus, members gain access to exclusive resources to conduct research and receive special rates to attend the PeDRA Annual Conference, taking place October 24-26, 2024, in Phoenix, AZ. We hope you will take advantage of this special opportunity for a discounted membership and join our community today! Click here to learn more about membership and mention the DNA Podcast in the “How did you hear about PeDRA?” on your application form to receive a special code.
In episode five of Getting to Know Your Research, Dr. Amy Paller discusses the history and significance of the recently published article in JAMA Dermatology titled, Stigmatization and Mental Health Impact of Chronic Pediatric Skin Disorders.Tune in to learn more about the origins of PeDRA's first major study, referred to as The “Big” Study, and discover how it has paved the way for future large-scale research within the organization.
To listen to Dr. Paller's interview on the JAMA Dermatology Author Interviews podcast, please click here.
In case you missed the annual Society for Investigative Dermatology meeting in May 2024 in Dallas, TX, PeDRA's Executive Director, Mike Siegel, PhD, and Carrie Coughlin, MD, MPHS are here with a recap of the meeting as well as the PeDRA session.
Dr. Coughlin is a pediatric dermatologist, and Associate Professor of Dermatology at Washington University School of Medicine in St. Louis. She also serves as the chair of PeDRA's outcomes committee.
For information about SID, please click here.
In episode four, PeDRA Pub Club host, Donglin Zhang and guest panelists, Stephen Humphrey, MD, Mary Larijani, MD, and Milie Fang, DO, discuss a recent PeDRA publication, Survey of Pediatric Dermatologist Views on Treatment for Alopecia Areata.This survey was published in JAAD International in December of 2023. Whether you’re a longtime pediatric dermatologist, currently in training, or a patient or advocate who wants to learn more about the latest research in pediatric dermatology this podcast is for you. In an approached roundtable discussion, listeners will gain insight into publications relating to pediatric dermatology and learn what the research means for patients and providers.
In episode four of Getting to Know Your Research, Dr. Lucinda Kohn and fourth-year medical student Micah Pascual discuss their 2022 PeDRA Research Fellowship project titled Daxpe: Native Skin Health Survey. Listen to learn more about how to design and implement a survey that aims to understand the needs of an underserved community.
In the second episode of Unraveling HS, program hosts Dr. Colleen Cotton and Dr. Irene Lara-Corrales are joined by expert panelists Dr. Jennifer Ruth, Dr. Jennifer Hsiao, and Dr. Rebecca Levy to examine five distinct HS cases. Listen in as they share insights on biosimilars, HS in Down syndrome, and managing comorbidities in both multidisciplinary and non-multidisciplinary clinical settings.
In episode three, PeDRA Pub Club host, Donglin Zhang and guest panelists, Christina Boull, MD, Diana Reusch, MD, and Cristina Foschi, MD, discuss a recent PeDRA publication, Successful Use of Telemedicine for Evaluation of Infantile Hemangiomas during the Early COVID-19 Pandemic: A Cross-sectional Study. This study was originally published in June 2022 in Pediatric Dermatology. Whether you’re a longtime pediatric dermatologist, currently in training, or a patient or advocate who wants to learn more about the latest research in pediatric dermatology, this podcast is for you. In an approachable roundtable discussion, listeners will gain insight into publications relating to pediatric dermatology and learn what the research means for patients and providers.
In our final Industry 101 episode we explore the vital role of Key Opinion Leaders (KOLs) in shaping industry trends, innovations, and healthcare practices. In this podcast we delve deep into the qualities industry is looking for in a KOL, why they are important, how to resolve conflicts when they arise, and what early investigators can do now to position themselves to become KOLS. Whether you’re a healthcare professional, industry insider, or simply curious about the inner workings of the pharmaceutical world, you’ll want to tune in to gain actionable insights, and a deeper understanding of the pivotal role KOLs play in driving progress and innovation in the field.
In episode three of Getting to Know Your Research, Dr. Joyce Teng and fourth-year medical student Austin Johnson discuss their 2022 PeDRA Research Fellowship, focusing on Epidermolysis Bullosa Simplex Disease Activity and Response Tool (EBSdart): Scoring Clinical Severity and Outcomes in Epidermolysis Bullosa Simplex. Learn more about their mentorship relationship and discover the process behind creating an assessment tool and its significance for patients.
In episode two, PeDRA Pub Club host, Donglin Zhang and guest panelists, Christina Boull, MD, Diana Reusch, MD, and Cristina Foschi, MD, discuss a recent PeDRA publication, Assessing Pain Catastrophizing and Functional Disability in Pediatric Epidermolysis Bullosa Patients. This study was originally published in May 2023 in Pediatric Dermatology. Whether you’re a longtime pediatric dermatologist, currently in training, or a patient or advocate who wants to learn more about the latest research in pediatric dermatology, this podcast is for you. In an approachable roundtable discussion, listeners will gain insight into publications relating to pediatric dermatology and learn what the research means for patients and providers.
April 20, 2023
Irene Lara-Corrales, MD is an associate professor of dermatology at the University of Toronto and a pediatric dermatologist at The Hospital for Sick Children (SickKids) in Toronto, Canada. She always knew she wanted to be a pediatric dermatologist, and her interest in epidermolysis bullosa (EB) grew deeper after treating a young baby with EB during her residency in Costa Rica. Most recently, she’s been championing Hidradenitis Suppurativa within PeDRA and the greater pediatric dermatology research community. Watch or listen to learn more about her passions, including her love of books and tea.
To listen to the new podcast - Unraveling HS, please click here.
In Episode Two of Getting to Know Your Research, Dr. Kristen Berrebi discusses her 2020 PeDRA Research Grant,A Multi-Center Retrospective Cohort Study on the Utility of Ancillary Studies in the Risk Assessment and Management of Spitz Nevi, Atypical Spitzoid Tumors, and Spitzoid Melanoma in the Pediatric Population. Learn more about this project and the pivotal contributions of medical students and trainees in the research process.
This podcast episode builds upon a previous Points of Discussion focused on Spitz Nevi. To listen to that discussion, please click here.
Dr. Yvonne Chiu discusses the findings of her collaborative study – Body site distribution of pediatric-onset morphea and association with extracutaneous manifestations. Learn about the different morphea categories, and whether or not certain locations of linear morphea are risk factors for extracutaneous involvement. This webinar originally aired in 2021. To view the video version of this presentation, please click here.
Dr. Streicher is an Assistant Professor at Indiana University School of Medicine. She’s currently co-chairing PeDRA’s Birthmarks Focused Study Group*. She became interested in pediatric dermatology while in medical school at Indiana University after completing a peds derm rotation with Dr. Anita Haggstrom. Her training took her to Georgia and Pennsylvania, and she’s come full circle back to Indiana to work alongside Dr. Haggstrom. Learn more about her work with the Birthmarks Focused Study Group and why she’s been reading so much by Julia Donaldson lately.
*This episode originally aired in May of 2021. The Birthmarks Focused Study Group is now chaired by Denise Metry, MD and Maria Buethe, MD, PhD. For more information please visit www.pedraresearch.org.
In this episode, PeDRA Pub Club host, Donglin Zhang and guest panelists, Christina Boull, MD, Diana Reusch, MD, and Cristina Foschi, MD discuss a recent PeDRA publication, Clinical Characteristics of Infantile Hemangiomas with Aggressive, Persistent, and Destructive Ulceration. This collaborative, multi-site, retrospective study was originally published on October 16, 2023, in Pediatric Dermatology and was supported by a 2016 PeDRA Team Research Grant and a 2021 PeDRA Study Support Grant. Whether you’re a longtime pediatric dermatologist, currently in training, or a patient or advocate who wants to learn more about the latest research in pediatric dermatology, this podcast is for you. In an approachable roundtable discussion, listeners will gain insight into publications relating to pediatric dermatology and learn what the research means for patients and providers.
Hidradenitis Suppurativa (HS) expert, Haley Naik, MD of the University of California, San Fransisco joins Drs. Cotton and Lara-Corrales for a comprehensive discussion about diagnosis and treating early onset HS in the clinic and highlights the specific research taking place globally to help change outcomes for pediatric patients suffering from this devastating condition.
Welcome to "How We Made it Count," a special podcast that takes you behind the scenes of the Eczema Counts project. This collaborative effort, fueled by an engagement award from the Patient Centered Outcomes Research Institute also known as PCORI, aimed to educate and inspire caregivers, patients, and researchers alike. Through a series of virtual games and in-person sessions, Eczema Counts went beyond conventional approaches and brought a unique blend of gamification and patient-centered outcomes research to the forefront. Listen as key members of the project reflect on its impact, share their thoughts for the future, and dive into the fascinating world of pediatric dermatology research and the innovative partnership between the Pediatric Dermatology Research Alliance and the National Eczema Association.
For more information visit PeDRA, the National Eczema Association, or Eczema Counts.
In case you missed it, PeDRA produced two sponsored webinars with Novan in the Spring of 2023. If you would like to view the video versions of these presentations, please click here. For more resources about molluscum, please click here.
As we gear up to release the first episode of our new Hidradenitis Suppurativa Podcast series, we dipping into the archives for a publication presentation from Dr. Irene Lara-Corrales about this international, multicenter, retrospective, cross-sectional study of 481 pediatric patients revealed a gap in diagnosis, and that HS patients are likely to suffer from other comorbidities. Learn more about the study, recommendations for managing patients with HS, and recommendations for future research. To view the video version of this presentation, please click here. Stay tuned for the upcoming HS series!
Dr. Markus Boos discusses the influence of gender and sexual identity in adolescent skin health. His findings reiterate the importance of recognizing implicit bias and ensuring sexual/gender minority (SGM) children are being treated with the same holistic, respectful care as non-SGM children. Watch to learn more. To view the video presentation of this program, please click here.
Season four of Getting to Know You shakes up our format with a new twist. This season, we are getting to know the amazing research that PeDRA members are doing. In our first episode, nurse practitioner, Emily Croce, PhD, MSN, APRN, CPNP-PC talks us through her 2022 Childhood Eczema Challenge grant, The Role of Outdoor Air Pollution on Disease Burden and Racial Ethnic Disparities. Learn how this project made use of existing data to reveal some key findings, the tools and methodology used in this study, and how this project is going to fuel future research into the intersection of atopic diseases and racial and ethnic disparities. You can view Emily's collaborative publication here.
Lisa Arkin, MD presents the findings of a PeDRA study: Clinical and Histologic Presentation of Pediatric Reactive Granulomatous Dermatitis. This program originally aired in May of 2020. To view the video version of this presentation, please click here.
In this mini Community Spotlight, PeDRA shines a light on The Association of Hidradenitis Suppurativa and Inflammatory Diseases (AHSID). Learn about the work AHSID does for the patient and provider communities in an interview with founder and CEO Jasmine Espy.
AHSID has volunteer opportunities! If you are interested in volunteering, please click here to apply.
To view the video version of this interview, please click here.
Olivia Davies, MD discusses the findings of a recent publication – Hamartomas and midline anomalies in association with infantile hemangiomas, PHACE, and LUMBAR syndromes. To view the video version of this program, please click here. This program originally aired in June of 2020.
Listen now to a special PeDRA Publication Presentation about a recent collaborative publication in the British Journal of Dermatology. Alexis Sokoloff is a young woman living with Down syndrome and hidradenitis suppurativa (HS), and together with Dr. Jillian Rork, Morgan Dykman, and Gwen Sokoloff, she discusses the publication and shares what she wants providers to know about treating HS in the Down syndrome community.
Co-editors of Pediatric Dermatology, Lionel Bercovitch, MD, and Andrea Zaenglein, MD, and chair of PeDRA’s Outcomes Committee, Carrie Coughlin, MD, MPHS, offer guidance to reviewers on how to evaluate a manuscript and advice to authors on preparing a strong manuscript for submission. These skill sets are not only important for career success, but they help make a positive impact in the field of pediatric dermatology. To view the video version of this program, please click here. This program originally aired in July of 2022.
The Drugs and Bugs Focused Study Group presents a spirited conversation on whether Reactive Infectious Mucocutaneous Eruption (RIME) should be a separate condition from Stevens-Johnson Syndrome (SJS). Moderated by Dr. Michele Ramien, Dr. Erin Mathes, and Dr. Yvonne Chiu debate RIME, SJS, and other blistering severe cutaneous adverse reactions. In this three-part miniseries, episode one presents the case for RIME, episode 2 states the case for SJS, and episode three is a moderated discussion between the two opposing sides to highlight the research still needed to come to a consensus, while also shedding light on active research in this area. The program originally aired in June of 2023.
Past PeDRA Research Fellowship Grant recipient, Angel D. Pagan Gonzalez, MD, presents this single-site research study about the success of Dupilumab in children and adolescents. Dupilumab Improves Clinical Scores in Children and Adolescents with Moderate to Severe Atopic Dermatitis. To view the video version of this presentation, please click here.
Blistering severe cutaneous adverse reaction in children: proposal for pediatric-focused clinical criteria. Dr. Michele Ramien summarizes a collaborative study on blistering severe cutaneous adverse reactions (SCAR) in children. It’s very important to diagnose these reactions early and accurately as they can be life-threatening. The study created categories that are more appropriate for diagnosing pediatric patients than what existed in the past. Watch to learn more about the impact on patients and the next steps. To view the video version of this program please click here.
Happy New Year and welcome to the January 8 Monday Re-release: Maximizing Relationships! Learn about maximizing relationships between attendings and trainees. Dawn Eichenfield, MD, PhD, Cheryl Bayart, MD, and A. Yasmine Kirkorian, MD along with their trainees share their wisdom in this round table discussion about creating a research relationship that’s mutually beneficial for both attendings and trainees. This podcast originally aired in May 2023.
In episode four, Dr. Harper Price facilitates a dynamic conversation alongside Beth Drolet, MD, and Michael Howell, PhD, exploring the significance of investigator-initiated studies. They delve into the reasons behind its importance and provide insights on when and how to initiate such studies. The discussion emphasizes that collaborating with industry and spearheading a study can be a manageable and rewarding experience, dispelling any apprehensions.
Presented by the Acne and Hidradenitis Focused Study Group and moderated by Dr. Irene Lara-Corrales, Drs. A. Yasmine Kirkorian, and Izzy Andrews discuss the treatment options for pediatric hidradenitis suppurativa and highlight the research that is still needed to understand and treat this devasting disease effectively. Listen to learn more. The program originally aired in May of 2022.
The Down syndrome sub-group presents a discussion on the use of immune modulators in children with Down syndrome. Moderated by Dr. Jillian Rork, Drs. Emily Gurnee, Kristen Holland, and Kishore Vellody take a deep dive into skin conditions and treatments for children with Down syndrome and highlight exciting new research on the horizon. This program originally aired in February of 2022.
So you’ve got the funding, now how do you make the research happen? Hear from three funded PeDRA investigators and learn how they assembled their teams, tackled the paperwork, and got their projects off the ground. Don’t miss this great opportunity to learn from their experiences! This program originally aired in April of 2021. View the video version of this presentation here.
Join Jennifer Schoch, MD as she discusses the successes of the research program at the University of Florida Dermatology and the importance of funding. This program originally aired in July of 2020. To view the original webinar, please click here.
Listen as Dr. Jen Schoch moderates a podcast discussion on the pros and cons of sunscreen use in children under the age of 6 months. Joined by two esteemed guests, Dr. Irene Lara-Corrales, and Dr. Jeannette Jakus, this conversation identifies not only the pros and cons, but offers sunscreen alternatives, and discusses future potential research projects. This program originally aired in December of 2021.
Season three concludes with an interview featuring Sonal Shah, MD. Dr. Shah is the Director of Pediatric Dermatology at University Hospitals Rainbow Babies & Children’s Hospital and holds the position of Associate Professor of Dermatology at Case Western Reserve University School of Medicine. Alongside Dr. Leah Lalor, she is a co-founder and co-leader of PeDRA’s newest Focused Study Group (FSG) – Education. Tune in to discover more about Dr. Shah’s research and ways to get involved in the Education FSG.
This is part two of a two-part miniseries about the importance and value of patient partners. Learn how to engage patients as research and data strategy partners with Suz Schrandt.
This program originally aired as a webinar in the spring of 2020. To view the webinar, click here.
This is part one of a two-part miniseries about the importance and value of patient partners. Learn how to engage patients as research and data strategy partners with Suz Schrandt.
This program originally aired as a webinar in the spring of 2020. To view the webinar, click here. Part two is up next!
The group discusses the current research and what the next steps are to better define these lesions, and when and how to treat them. They also answer questions from our live studio audience.
To learn more about current PeDRA studies, please click here.
Dr. Berrebi discusses her parameters for monitoring vs. excision and Dr. Gerami discusses how to uncover the true nature of the lesion through a variety of testing options.
The group discusses the ever-changing terminology and why it matters. Listen as episode one lays the foundation for a great discussion on genomics.
We are rounding out EB Awareness Week with this Monday’s Podcast Rerelease. Originally airing in April of 2021, this Abeona Sponsored Webinar, Gene Therapy for Large Chronic Wounds in Recessive Dystrophic Epidermolysis Bullosa, was presented by Jean Tang, MD, PhD. Dr. Tang provided an update on the EB-101 pivotal Phase 3 VIITAL study and answered questions from the audience.
To view the original webinar, please click here.
In honor of Epidermolysis Bullosa (EB) awareness week starting today, we are re-releasing an audio version of an Amryt Pharma-sponsored webinar that originally aired in December of 2021. Listen as Dr. John Browning from Baylor College of Medicine and Dr. Lara Wine-Lee from the Medical University of South Carolina discuss a promising new treatment for wound healing in EB patients.
Click here to view the video version of this webinar.
PeDRA member, Colleen Cotton, MD, recently presented at the 2023 Symposium on Hidradenitis Suppurativa Advances (SHSA). In this episode, Dr. Colleen Cotton sits down with PeDRA to give a quick summary of the SHSA meeting and make a special announcement about an upcoming PeDRA educational initiative. SHSA is an annual meeting organized by the Hidradenitis Suppurativa Foundation (HSF) to bring experts from around the world to share their experiences with HS. ICYMI: PeDRA is thrilled to support HS Research through the 2023 Hidradenitis Suppurativa Pilot Grant! The deadline to apply is December 7, 2023 and you can learn more here.
PeDRA had the privilege of attending the Symposium on Hidradenitis Suppurativa Advances (SHSA) in Phoenix, AZ in October 2023. During the meeting, PeDRA’s Associate Director of Educational Programs interviewed three amazing presenters to discuss the incredible work being done in this space. First up is Lynn Petukhova, PhD, discussing her ground-breaking work in Hidradenitis Suppurativa (HS) genetics and how she harnesses the power of genome-wide association studies (GWAS). Following this, you’ll gain insight into more HS research through two poster interviews with MD candidates Nicholas Chiang and Sydney Dong, respectively. For more information on Dr. Petukhova’s work, or to submit a case study, please visit the Columbia University Data Science Institute.
SHSA is an annual meeting organized by the Hidradenitis Suppurativa Foundation (HSF) to bring experts from around the world to share their experiences with HS.
Get to know Cristy Garza-Mayers, MD, PhD. Dr. Garza-Mayers is an Instructor at Harvard Medical School and a pediatric dermatologist at Mass General Brigham with an interest in vitiligo. In addition to her work on PeDRA's Early Investigator Committee, she also serves as a mentor through the PeDRA Mentorship Program and has received funding for her research projects through two grant programs. Learn more about her research, what led her to pediatric dermatology, and listen to the end to hear her answer some fun, rapid fire questions.
This the final episode of the 6-part series on Emerging Therapies for Moderate to Severe Atopic Dermatitis in Children. Join Dr. Dawn Davis from the Mayo Clinic in this final episode on Systemic Therapies for Moderate-to-Severe AD in children, for a conversation with Wendy Smith-Begolka, MBS from the National Eczema Association and Korey Capozza, MPH from Global Parents for Eczema Research. Together they answer questions and discuss the importance and value of research. This program originally aired in January of 2021.
www.nationaleczema.org
www.parentsforeczemaresearch.com
www.pedraresearch.org
Our Monday Re-Release series on Emerging Therapies for Moderate to Severe Atopic Dermatitis in Children concludes with the first of two Townhall podcasts. Listen to hear distinguished faculty in pediatric dermatology and allergy/immunology answer questions about new and emerging treatments and important research issues for moderate-to-severe atopic dermatitis in children. Special guests Dr. Emma Guttman-Yassky and Dr. Eric Simpson. This program originally aired in January of 2021.
Join Dr. Dawn Davis from the Mayo Clinic for a conversation with two patient advocates as they discuss the patient experience with new and traditional AD therapies and share thoughts on how patients and providers can best work together. This program originally aired in December of 2020.
Monday Re-release continues with the first of two podcasts from the Emerging Therapies for Moderate to Severe Atopic Dermatitis in Children series. Listen as distinguished faculty in pediatric dermatology and allergy/immunology talk about new and emerging treatments and important research issues for moderate-to-severe atopic dermatitis in children. This program originally aired in November of 2020.
Industry 101 is back with Episode 3 – Working with Large and Small Pharma. In this episode, Dr. Harper Price discusses the differences between companies with special guests Dr. Michael Howell and Dr. Jim Lee. Listen to discover insightful strategies for networking with both large and small companies and learn how the differences between companies are not so vast after all. Click here to listen to previous episodes.
Monday Re-release continues with the second webinar in the Emerging Therapies for Moderate to Severe Atopic Dermatitis in Children series – Pediatric Atopic Dermatitis: Algorithms for the Future. Featured guests offer presentations and discussions on emerging topical therapies, new and traditional systemics, considerations when choosing the right treatment for the right patient, and hot research topics for moderate-to-severe atopic dermatitis in children. To view the original recording of this program, please click here.
It’s Eczema Awareness Month, so this Monday Re-release is PeDRA’s first multi-episode educational series - Emerging Therapies for Moderate to Severe Atopic Dermatitis in Children. Listen to two programs originally aired as webinars in the fall of 2020. This episode features presentations about biologics, JAK inhibitors, and allergy perspectives for the treatment of pediatric atopic dermatitis. To view the original recording of this program, please click here.
Continuing the Building a Research Survey series with part two – Designing an Online Survey. To view the original webinars, please click here.
Today’s Monday Re-Release is PeDRA’s three-part series on survey writing. Originally airing in the spring of 2021 as a webinar series, this three-part program provides a high-level overview of the design, execution, and analysis of an online research survey. Covering everything from building a survey team to sampling techniques to data collection and preparation for publication, this series will position investigators for success and protect the time and attention of busy survey respondents. To view the original webinars, please click here.
The final installment of the Building a Research Survey series is Preparing a Survey and Gathering Data. To view the original webinars, please click here.
This special episode is part of the Eczema Counts game, a collaborative education initiative between the National Eczema Association (NEA) and PeDRA. In this episode, you’ll hear from two leaders of the Eczema Counts project: Dr. Joy Wan, assistant professor of dermatology at Johns Hopkins University, and Silena Gaines, a caregiver for a child with eczema. Learn about how Dr. Wan and Silena have worked together to improve the quality of care and long-term outcomes for eczema patients, and how the Eczema Counts game has brought researchers, patients, and caregivers together to further their knowledge in patient-centered research. Click here to register for the PeDRA Conference.
Get to know the 11th PeDRA Annual Conference with special guests, Conference co-chairs Lisa Arkin, MD, and Esteban Fernandez Faith, MD. Learn more about the philosophy behind the PeDRA meetings, how to make the most of the meeting, and how patients are at the heart of our community collaboration. The PeDRA Conference is taking place in Atlanta, GA, November 9-11, 2023. Register Today!
This is the third and final podcast in the Monday Alopecia Areata re-release. Dr. Britt Craiglow interviews a patient family living with alopecia areata. Gracie, a 13-year-old, 8th grader shares her own alopecia areata experience with her rapid hair loss right before beginning middle school, and the importance of being involved in a clinical trial. Her inspiring story offers comfort to other children with alopecia areata and reminds us all why research is so important. Please note, this episode originally aired in September 2021.
This is the second podcast in the Monday Alopecia Areata re-release. Dr. Leslie Castelo-Soccio and Dr. Britt Craiglow answer questions submitted by the PeDRA community. They discuss their approaches to steroids, how to talk oral systemics with patients and caregivers, and identify several research priorities for the future. If you’d like to get involved or learn more about the research ideas discussed in this episode, please send an email to info@pedraresearch.org to be connected with PeDRA’s Hair Disorders Focused Study Group. Please note, this episode originally aired in August of 2021.
We’re continuing our focus on alopecia areata awareness month with the final three podcasts from the Pfizer-funded series - Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Alopecia Areata in Children. In this episode, Dr. Carolyn Goh shares her views on patient care, how to find the right treatment for each patient, and her own experience growing up with alopecia. Providing personal insights on everything from the stigma of the disease to potential future treatments, Dr. Goh offers a refreshing perspective on difficult conversations with patients and the options available to them for treating, or not treating their hair disorders. Dr. Goh is a dermatologist, and Associate Clinical Professor of Dermatology at the David Geffen School of Medicine at UCLA. Looking for patient resources? Visit the National Alopecia Areata Foundation website.
Please note this program originally aired in June of 2021.
This is the third and final webinar in the Monday Alopecia Areata re-release. Dr. Rodney Sinclair presents cutting-edge clinical trial data and discusses emerging mechanisms of action in the treatment of Alopecia Areata in children. To view the video version of this webinar, please click here. Please note this webinar originally aired in June of 2021.
Two of our dedicated PeDRA members, Amy Paller, MD and Andrea Rustad, a fourth-year medical student at Northwestern University Feinberg School of Medicine, recently published a children’s book, Skin-Vincible, in collaboration with the Foundation for Ichthyosis & Related Skin Types. Through the experiences of its main character, Cece, this book addresses skin differences and how to cope with bullies. Watch and learn how this book was made and why it’s an important tool for parents, teachers, and children in addressing bullying and differences. Click here to buy the book. To watch this interview on PeDRA's YouTube Channel, click here.
In part two of our Community Spotlight podcast featuring the Foundation for Ichthyosis and Related Skin Types (FIRST) you’ll hear from the Cina Family as they discuss the important role patient advocacy organizations play in supporting families. Sean and Jolie Cina have two children with ichthyosis – Portia (16) and Miles (12), and found FIRST shortly after Portia was born and diagnosed. Now, 16 years later, the family is more involved than ever with the FIRST community. Inspired by her own condition, Portia created and produced a documentary about living with ichthyosis, called Beneath the Skin (you can watch this and other related videos on Portia’s YouTube Channel here). Enjoy this episode as you learn more about ichthyosis and the Cina’s experience with FIRST.
Community Spotlight is back with new episodes and we’re proud to be shining a light on the Foundation for Ichthyosis and Related Skin Types, more commonly known as FIRST! This incredible organization has been supporting patients, families, and caregivers, as well as funding research for more than 40 years. Listen to Chief Executive Officer, Chris Boynton as he shares his journey into rare disease advocacy, and highlights ways both patients, families, and investigators can become involved.
Diana Zarowin is a fourth-year medical student at Albert Einstein College of Medicine. From the moment she joined PeDRA, Diana hit the ground running, participating in Focused Study Groups, applying for the PeDRA Mentorship Program, attending the PeDRA Annual Conference, and working with her mentors to prepare successful grant and fellowship applications. To date, she is the recipient of an Emerging Investigator Research Grant under the mentorship of Dr. Britt Craiglow and a PeDRA Research Fellowship award with Dr. James Treat. Most recently, she joined forces with Mattel to champion the Barbie Like Me campaign, putting dermatology-represented Barbies into the hands of young patients. Learn more about this incredible project, how her research supported by PeDRA has influenced her career aspirations, and the types of books she enjoys reading in her limited spare time. For more information about the Barbie Like Me campaign, please email PeDRA.
PeDRA member Emily Croce, PhD, CPNP-PC presents this collaborative research study that was partially funded by a 2021 PeDRA Research Fellowship: Validation of Remote Atopic Dermatitis Severity Assessment with the Eczema Area and Severity Index in Children Using Caregiver-provided Photos and Videos. To view the video version of this presentation, please click here.
We invite you to join us for the Innovation Forum taking place at the 11th PeDRA Annual Conference, November 9-11, 2023. The Innovation Forum is a workshop designed to engage conference attendees in learning how to identify important real-world problems related to pediatric dermatology and ways to develop innovative solutions to solve them. Led and facilitated by Lilit Garibyan, MD, PhD, Kachiu Lee, MD, and Yakir Levin, MD, PhD of the Magic Want Initiative. The deadline to enroll is 5pm PT, Thursday, October 12. Please click this link for more information and to register. If you have questions, please contact us at conference@pedraresearch.org.
Bella Plumptre, MD is in her final year of dermatology residency at the University of Massachusetts. Hailing from England, Dr. Plumptre found her passion for pediatric dermatology while doing a pediatric dermatology rotation in London, where she “she found her people.” Cut to a few years later, she began studying in the US and sees herself in the academic setting in the future. Learn more about Dr. Plumptre’s research interests and global adventures, including her love of tandem biking all over the world.
Pachyonychia Congenita is a rare and extremely painful dermatologic disease. For many patients, a clear diagnosis isn’t even made until adulthood. PC Project aims to change that with a patient registry and free genetic testing. Patients and families come to PC Project for support from a community that knows and understands them, but also to advance the science. Due to the success of the international registry, data provided by patients is fueling research at an accelerated pace. You can learn more about PC Project and ways to get involved by visiting www.pachyonychia.org.
Pachyonychia Congenita is a rare and extremely painful dermatologic disease. For many patients, a clear diagnosis isn’t even made until adulthood. PC Project aims to change that with a patient registry and free genetic testing. Patients and families come to PC Project for support from a community that knows and understands them, but also to advance the science. Due to the success of the international registry, data provided by patients is fueling research at an accelerated pace. Hit play to learn about PC Project through a special interview with Janice Schwartz, PC Project’s Executive Director. You can learn more about PC Project and ways to get involved by visiting www.pachyonychia.org.
Hidradenitis Suppurativa (HS) is a devastating inflammatory skin disease that is painful, stigmatizing, and under-researched in the pediatric population. PeDRA is shining a light on this often-overlooked disease with HS Connect, a patient advocacy organization committed to promoting research and providing resources to everyone in the HS community. HS Connect offers virtual support groups, works with the medical research community, and promotes HS education and awareness all in the name of fueling research that will lead to better outcomes for those suffering from HS.
Hidradenitis Suppurativa (HS) is a devastating inflammatory skin disease that is painful, stigmatizing, and under-researched in the pediatric population. PeDRA is shining a light on this often-overlooked disease with HS Connect, a patient advocacy organization committed to promoting research and providing resources to everyone in the HS community. HS Connect offers virtual support groups, works with the medical research community, and promotes HS education and awareness all in the name of fueling research that will lead to better outcomes for those suffering from HS.
This is a rerelease interview from October 2021 with the National Eczema Association.
Eczema’s range in severity means each patient experience is different from the next and no two stories are the same. Young Ella has lived with severe eczema since she was 8 months old. Now, as a 6-year-old in first grade, she’s finally able to experience some relief and feel like a “normal” kid. Ella and her mom, Amy share their story, how the National Eczema Association helped them navigate this disease, and how Ella was finally able to eat ice cream and go to the beach.
National Eczema Association
In October 2021, PeDRA highlighted the National Eczema Association. This incredible organization supports patients, families, and caregivers, through a variety of activities and resources. NEA also supports research through a robust funding program, as well as its own research through surveys and the EczemaWise app. NEA’s Vice President of Scientific and Clinical Affairs, Wendy Smith-Begolka, MBS discusses the research taking place now and how future research will impact patients, families, and caregivers.
www.nationaleczema.org
Part two of our community spotlight tells the story of a shy young woman struggling with atopic dermatitis and her journey to self-confidence through her experiences at Camp Wonder as both a camper and then a counselor. Mikaela, along with her mother Diana discuss how life-changing Camp Wonder has been for them both. Learn all about the Leap of Faith tower, and see firsthand how Camp Wonder changes lives.
Children with skin diseases don’t get to experience childhood in the same way as children without skin diseases. In this Community Spotlight, we sit down with Francesca Tenconi, the founder and executive director of the Children’s Skin Disease Foundation to talk about their program Camp Wonder! Camp Wonder is a place where children get to be kids, without the burden of their disease taking center stage. Camp Wonder’s unique approach allows children to put their childhood first and gives their parents and siblings a much-needed rest from doctor’s appointments, sleepless nights, and all the other burdens that come with skin disease. Learn more about CSDF here.
This episode originally aired in February 2022.
Episode Three:
Dr. Ramien moderates a discussion between the two opposing sides to highlight the research still needed to come to a consensus, while also shedding light on active research in this area.
The Drugs and Bugs Focused Study Group presents a spirited conversation on whether Reactive Infectious Mucocutaneous Eruption (RIME) should be a separate condition from Stevens-Johnson Syndrome (SJS). Moderated by Dr. Michele Ramien, Dr. Erin Mathes, and Dr. Yvonne Chiu debate RIME, SJS, and other blistering severe cutaneous adverse reactions.
Episode Two: The Case for Stevens-Johnson Syndrome (SJS)
Dr. Yvonne Chiu discusses the confusion it can create when RIME is called out as a separate condition from SJS.
The Drugs and Bugs Focused Study Group presents a spirited conversation on whether Reactive Infectious Mucocutaneous Eruption (RIME) should be a separate condition from Stevens-Johnson Syndrome (SJS). Moderated by Dr. Michele Ramien, Dr. Erin Mathes, and Dr. Yvonne Chiu debate RIME, SJS, and other blistering severe cutaneous adverse reactions.
Episode One: The Case for RIME
Dr. Erin Mathes discusses her clinical approach to RIME patients and highlights the reasons for keeping RIME as its own, independent condition.
The Drugs and Bugs Focused Study Group presents a spirited conversation on whether Reactive Infectious Mucocutaneous Eruption (RIME) should be a separate condition from Stevens-Johnson Syndrome (SJS). Moderated by Dr. Michele Ramien, Dr. Erin Mathes, and Dr. Yvonne Chiu debate RIME, SJS, and other blistering severe cutaneous adverse reactions.
Yakir Levin, MD, PhD is a Physician Scientist and Dermatologist at Massachusetts General Hospital, Instructor in Dermatology at Harvard Medical School, and an Investigator at the Wellman Center for Photomedicine. Watch to learn more about Dr. Levin’s interest in both medicine and electrical engineering and how he takes an interdisciplinary approach to bring the best possible care to his patients and their families.
PeDRA's Associate Director of Educational Programs had a chance to meet with several ISID attendees to get their take on the amazing science being presented at the inaugural International Societies for Investigative Dermatology meeting in Tokyo, Japan this last month. If you'd like to watch the video versions of these interviews, please click here.
Listen as PeDRA's Associate Director of Educational Programs, Jenn Dawson interviews several poster presenters at the ISID meeting in May 2023 in Tokyo, Japan. The interviews include a reference to an EB/Squamous Cell Carcinoma clinical trial. You can find more information about that trial here.
You can also view the on-camera interviews referenced in this episode here.
Cathryn Sibbald, MD, MSc is a dermatologist at the Hospital for Sick Children (SickKids) in Toronto, Canada. In addition to treating children, Dr. Sibbald also treats adults in community hospitals, providing her with the unique opportunity to continue caring for many patients that she treated as children. She is the co-chair of PeDRA’s Hair Disorders Focused Study Group and serves on both the PeDRA Grants and PeDRA Outcomes Committees. Listen now to learn more about Dr. Sibbald’s work, how she originally wanted to be a pharmacist before pursuing dermatology, and how she became a pet-parent during the pandemic.
Learn about maximizing relationships between attendings and trainees. Dawn Eichenfield, MD, PhD, Cheryl Bayart, MD, and A. Yasmine Kirkorian, MD along with their trainees share their wisdom in this round table discussion about creating a research relationship that’s mutually beneficial for both attendings and trainees.
This webinar offers presentations from Nanette Silverberg, MD, and Adelaide Hebert, MD to discuss the renewed interest in understanding the pathophysiology of molluscum and the importance of treatment versus a “watch and wait” strategy. Implications on patient quality of life and burden of illness are also discussed as well as managing difficult molluscum cases. Emerging therapeutic strategies are also reviewed.
This program is sponsored by Novan.
Click here to view the presentation slides.
Irene Lara-Corrales, MD is an associate professor of dermatology at the University of Toronto and a pediatric dermatologist at The Hospital for Sick Children (SickKids) in Toronto, Canada. She always knew she wanted to be a pediatric dermatologist, and her interest in epidermolysis bullosa (EB) grew deeper after treating a young baby with EB during her residency in Costa Rica. Most recently, she’s been championing Hidradenitis Suppurativa within PeDRA and the greater pediatric dermatology research community. Watch or listen to learn more about her passions, including her love of books and tea.
Listen to Dr. Harper Price and Dr. Lee Zane discuss Dr. Zane's unique experience in academic research as well as pharma. Dr. Zane shares his insights on everything from the keys to designing a good clinical trial to forming research questions that are valuable to achieving both clinical and industry regulatory goals.
Maria Teresa García-Romero, MD, MPH is an attending physician and assistant professor at the National Institute of Pediatrics in Mexico. She currently serves on PeDRA’s Grants Committee and is a former member of the Early Investigator Committee. Her research interests include morphea, vascular anomalies, EB, and more. Listen to hear about her multi-country research collaborations and advice for international clinician scientists.
Dr. Jennifer Schoch presents her recent collaborative study on Skin Microbiome Sampling in the Preterm Neonate.
Jerome Coulombe, MD is an associate professor of pediatrics and dermatology at the University of Montreal and a pediatric dermatologist at Saint Justine Hospital. Dr. Coulombe is active in PeDRA’s Drugs and Bugs Focused Study Group and his research interests include recurrent reactive infectious mucocutaneous eruption (RIME) and vascular anomalies in children. He enjoys sharing his goofy side with his patients and has some amazing karaoke skills. Watch to learn more about Dr. Coulombe.
The series kicks off with Episode 1: Intro to Industry with the series’ chair, Harper Price, MD. Discover how Dr. Price’s creative energy and passion for helping patients are the reasons she partners with industry and leads clinical trials. The episode wraps up with questions from a live studio audience and a preview of what’s ahead in the Industry 101 series.
We’re kicking off Season Three of Getting to Know You with PeDRA's President, Anna Bruckner, MD! Dr. Bruckner is a professor of dermatology and pediatric dermatologist at the University of Colorado. As one of PeDRA’s original founding members, she has served on countless committees over the years and is excited about her new role as the PeDRA President for the 2022-2024 term. Her dedication to research, particularly focused on epidermolysis bullosa, is making an impact in the field of pediatric dermatology and patient care. Watch now to learn more about her research and path to pediatric dermatology.
Episode Three: A Discussion
All three expert guests answer questions from the trainee studio audience to shed light on what is still unknown about the treatment of pediatric CMN.
Episode Two: Monitoring
Dr. Ilona Frieden shares her thoughts in favor of monitoring and the use of other interventions before laser therapy in the treatment of pediatric CMN.
Episode One: An Overview of Laser Therapy for the Treatment of CMN in Children.
Dr. Rox Anderson and Dr. Yakir Levin share their expert opinions on the benefits and challenges of laser therapy for the treatment of pediatric CMN.
PeDRA is proud to partner with the National Foundation for Ectodermal Dysplasias (NFED) to present a webinar about Diagnosing and Treating Ectodermal Dysplasias: Dermatological Manifestations of Ectodermal Dysplasias and Patient Case Presentation. This webinar provides an overview of the ectodermal dysplasias, the associated dermatological manifestations, and the importance of patient advocacy groups. Please note this is an audio version for a recorded webinar. To watch the webinar, https://youtu.be/cYeQD5leyj8 (please click here). For more information, please visit www.nfed.org.
Muskaan Sachdeva, MD from the University of Toronto discusses the findings of this collaborative study.
Hello dear listeners! There is so much happening this month, that I decided to take a few minutes to fill you in. Please listen and then click these links for more details. https://pedraresearch.org/grants-awards/ (PeDRA Grants) https://pedraresearch.org/pedra-mentorship-program/ (PeDRA Mentorship Program) https://pedraresearch.org/2022-annual-conference/ (Conference Registration) https://survey.alchemer.com/s3/6965013/Points-of-Discussion-2022-Survey (Points of Discussion Survey)
Hello, Points of Discussion fans! Season one has officially wrapped and we want to know how we did. Please take https://survey.alchemer.com/s3/6965013/Points-of-Discussion-2022-Survey (THIS) brief one-minute survey to provide important feedback. Season two is coming this fall - so stay tuned! https://pedraresearch.org/pedra-points-of-discussion/ (www.pedraresearch.org/pedra-points-of-discussion)
Co-editors of Pediatric Dermatology, Lionel Bercovitch, MD, and Andrea Zaenglein, MD, and chair of PeDRA’s Outcomes Committee, Carrie Coughlin, MD, MPHS, offer guidance to reviewers on how to evaluate a manuscript and advice to authors on preparing a strong manuscript for submission. These skill-sets are not only important for career success, but they help make a positive impact in the field of pediatric dermatology. Watch the full presentation https://youtu.be/6GThiEjGjYc (here).
Dr. Marla Jahnke discusses the findings of her most recent collaborative study – Care of Congenital Melanocytic Nevi (CMN) in Newborns and Infants: Review and Management Recommendations. Learn more about the current state of knowledge around CMN care and monitoring and recommendations for future guidelines. https://youtu.be/jIhv8zjB9K0 (Watch Video)
PeDRA staff had the opportunity to attend the 2022 SID Meeting. While there, PeDRA conducted a series of short interviews with attendees and presenters like John Harris, MD, PhD, and Joel Gelfand, MD, MSCE, FAAD, to capture some exciting meeting highlights.
Unanswered Questions in Pediatric HS The group addresses lingering research questions and stresses the importance of disease education in order to meet the needs of Hidradenitis Suppurativa (HS) patients. Consensus guidelines exist for adult HS but have yet to be written for pediatric HS. The need for early diagnosis is not only critical for disease management but is vital for the overall well-being of patients and their families.
Aggressive Options for Pediatric HS Dr. Lara-Corrales and Dr. Izzy Andrews discuss aggressive treatments for Hidradenitis Suppurativa (HS) and highlight the importance of a multi-disciplinary care team to help treat the psychosocial aspects and the physical pain associated with this traumatic disease. Access to care is also a key component in combating HS and it’s critical that more than just pediatric dermatologists have a better understanding of HS before treating patients.
Non-Aggressive Options for Pediatric HS Dr. Irene Lara-Corrales and Dr. Yasmine Kirkorian discuss non-aggressive treatment options available to pediatric patients with Hidradenitis Suppurativa (HS) and how difficult it can be to quantify just exactly what it means when providers recommend “lifestyle” changes to help treat this devastating inflammatory skin disease.
Exciting New Research In this final episode, the group discusses current research efforts and the research that is still needed to better understand the long-term-use effects of immune modulators, and how to approach conversations about using these medications with both patients and families. If you are interested in or have patients you would like to enroll in the University of Colorado Immune Skin Conditions Clinical Trial, please https://medschool.cuanschutz.edu/linda-crnic-institute/research/immune-skin-clinical-trial (click here) for more information.
The Pros and Cons of Immune Modulators The group weighs the pros and cons of using immune modulators, and how to manage concerns and expectations in the exam room with both patients and parents.
An Overview of Skin Diseases Seen in Children with Down Syndrome Moderated by Jillian Rork, MD, the group discusses the skin conditions in children with Down syndrome that require treatment with immune modulators.
In this PeDRA Early Investigator webinar, http://www.gailgazelle.com (Gail Gazelle, MD), teaches about the neuroscience of Imposter Syndrome, who it affects, why and how it develops, and practical strategies to leave it behind! https://pedraresearch.org/2022/01/31/impostor-webinar/ (Click here) to download an imposter syndrome worksheet.
Treatments for moderate-to-severe atopic dermatitis in children have made huge strides in recent months. Listen to Lawrence Eichenfield, MD, Emma Guttman-Yassky, MD, PhD, Candrice Heath, MD, and Minnelly Luu, MD discuss these advancements, what they mean for patients, and the importance of present and future research. This is a follow-up podcast to the https://pedraresearch.org/2020/09/25/2020-mod-severe-ad-ed/ (Emerging Therapies in the Treatment of Moderate-to-Severe Atopic Dermatitis in Children) educational series that aired in 2020.
Identifying Research Gaps In this final episode, the group discusses what research is still needed to better understand the risks and benefits of JAK inhibitors for the treatment of moderate-to-severe atopic dermatitis in children.
JAK Inhibitors versus Biologics The group weighs the pros and cons of these treatments options and discusses whether or not they would use them together in severe cases of atopic dermatitis in children. They also highlight the importance of considering overall patient emotional and mental health when looking at these different treatment options.
JAK Inhibitors versus Traditional Therapies Moderated by Minnelly Luu, MD, this Points of Discussion series features guest speakers Amy Paller, MD, Elaine Siegfried, MD, A. Yasmine Kirkorian, MD, and Jeff Yu, MD. Listen as the group discusses whether or not they would prescribe oral JAK inhibitors over traditional therapies for the treatment of moderate-to-severe atopic dermatitis in children. They discuss the cases in which they have done so and why.
In this final episode, Dr. Jakus and Dr. Lara-Corrales come together to share their thoughts on the research needed to safely recommend sunscreen use in children under the age of 6 months. They discuss how to manage the fine line of promoting limited sun exposure, while also recommending sunscreen.
In this second episode, Dr. Jeannette Jakus presents an argument in favor of sunscreen use in infants under 6 months. She discusses the safety of zinc oxide in diaper creams and how that same ingredient is used in sunscreen. She shares the importance of clear messaging and the need for a consensus on how sunscreen recommendations are presented to parent Listen and learn more.
In episode one, Dr. Irene Lara-Corrales discusses reasons to be cautious when using sunscreen in children under the age of 6 months. She highlights the research gaps in the infant skin barrier and the effects sunscreen may have on such young skin. She also outlines alternatives to sunscreen use by discussing sun-protective clothing. Listen to learn more.
In this PeDRA webinar, sponsored by Amryt Pharma, Dr. John Browning and Dr. Lara Wine-Lee present new information on epidermolysis bullosa research, as well as answer audience questions. To watch this webinar, please https://youtu.be/pGM9hXQ6c9g (click here). For more educational programming please visit: www.pedraresearch.org/education
Blistering severe cutaneous adverse reaction in children: proposal for pediatric-focused clinical criteria (I will link this). Dr. Michele Ramien summarizes a collaborative study on blistering severe cutaneous adverse reactions (SCAR) in children. It’s very important to diagnose these reactions early and accurately as they can be life-threatening. The study created categories that are more appropriate for diagnosing pediatric patients than what existed in the past. Watch to learn more about the impact on patients and next steps. Note to listeners: please turn up your volume.
In this final episode, Dr. Lindstrom and Dr. Frieden discuss the value of the program and changes that could be made to better serve patients and still protect the original aim of the program. Listen to learn more about how transparency might just be the key to achieving both the program goals, as well as supporting all patients fairly and safely.
In episode two of three, Dr. Ilona Frieden outlines the challenges providers and patients face with the iPledge program. Listen as Dr. Frieden raises important, thought-provoking issues like how the program impacts those who are not able to become pregnant and perpetuates health care access disparities. Dr. Ilona Frieden is a pediatric dermatologist and Professor of Dermatology at the University of California, San Francisco. She is the President of the Pediatric Dermatology Research Alliance and co-chair of the American Academy of Dermatology Association iPledge Workgroup.
In the first episode of this three-part miniseries, Is IPLEDGE Working? A Conversation on Risk Management and Isotretinoin, Dr. Leah Lalor talks about the program’s history with Dr. Jill Lindstrom. Listen as Dr. Lindstorm shares important information on the evolution of this REMS (Risk Evaluation and Mitigation Strategy) program for isotretinoin and how the program was molded into what it is today. Dr. Lindstrom is a practicing dermatologist at Walter Reed National Military Medical Center. She was previously the Deputy Director of the Division of Dermatology and Dental Products at FDA, where she worked for 17 years.
Dr. Markus Boos discusses the influence of gender and sexual identity in adolescent skin health. His findings reiterate the importance of recognizing implicit bias and ensuring sexual/gender minority (SGM) children are being treated with the same holistic, respectful care as non-SGM children. Watch to learn more. Watch the complete presentation https://pedraresearch.org/2021/10/19/webinar-influence-of-gender-and-sexual-identity-in-adolescent-skin-health/ (here).
Medical student and PeDRA Member, Mitchell Braun outlines this collaborative, multi-site chart review of persistent dysesthesias in involuted infantile hemangiomas. Learn the definitions of some commonly used medical terms and recommendations for future studies. Watch the complete presentation https://pedraresearch.org/2021/10/19/webinar-persistent-dysesthesias-in-involuted-infantile-hemangiomas/ (here).
In this final installment of the https://pedraresearch.org/2021/04/17/series-emerging-mechanisms-of-action-in-the-treatment-of-moderate-to-severe-alopecia-areata-in-children/ (Emerging Methods of Action in the Treatment of Moderate-to-Severe Alopecia Areata) series, Dr. Britt Craiglow interviews a patient family living with alopecia areata. Gracie, a 13-year-old, 8th grader shares her own alopecia areata experience with her rapid hair loss right before beginning middle school, and the importance of being involved in a clinical trial. Her inspiring story offers comfort to other children with alopecia areata and reminds us all why research is so important. Download this episode to learn more.
In the third part of the https://pedraresearch.org/2021/04/17/series-emerging-mechanisms-of-action-in-the-treatment-of-moderate-to-severe-alopecia-areata-in-children/ (Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Alopecia Areata in Children) series, Dr. Rodney Sinclair presented cutting edge clinical trial data and discussed emerging mechanisms of action in the treatment of Alopecia Areata in children. This webinar is being provided in audio format for on-the-go convenience. To watch the video version of this presentation, please https://youtu.be/iVshCmDGeUo (click here).
In the second installment of the https://pedraresearch.org/2021/04/17/series-emerging-mechanisms-of-action-in-the-treatment-of-moderate-to-severe-alopecia-areata-in-children/ (Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Alopecia Areata in Children) series, featured guests Dr. Ali Jabbari and Dr. John O’Shea dive into the science of AA. Dr. Jabbari will discusses his translational approach to elucidate new targets for AA and Dr. O’Shea will discusses his groundbreaking work to identify JAK inhibitors as a novel therapy for numerous immune-mediated diseases. This webinar is being presented in audio format for on-the-go convenience. To view the video version of this presentation, please https://youtu.be/W7AWNQT92Yw (click here).
In part one of https://pedraresearch.org/2021/04/17/series-emerging-mechanisms-of-action-in-the-treatment-of-moderate-to-severe-alopecia-areata-in-children/ (The Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Alopecia Areata in Children) series, Dr. Leslie Castelo-Soccio and Dr. Britt Craiglow discuss current clinical practices in treating pediatric patients with alopecia areata (AA), diving into the challenges both providers and patients face, and offering guidance on how to approach patients and their families in the clinical setting. This webinar is being presented in audio format for on-the-go convenience. To view the video version of this presentation, please https://youtu.be/70X8XNl8MKY (click here).
Dr. Yvonne Chiu discusses the findings of her most recent collaborative study - Body site distribution of pediatric-onset morphea and association with extracutaneous manifestations. Learn about the different morphea categories, and whether or not certain locations of linear morphea are risk factors for extracutaneous involvement. Watch the complete presentation https://youtu.be/YaUvoiuC-nE (here).
Dr. Colleen Cotton discusses the findings of her most recent collaborative study - Association of Demographic Factors and Infantile Hemangioma Characteristics with Risk of PHACE Syndrome. Learn more about hemangioma patterns that might suggest greater or lower risk for PHACE Syndrome and how to identify a high-risk patient for a full PHACE Syndrome work up. Watch the full presentation https://youtu.be/c308pad1_4E (here).
In the “Ask Me Anything” episode of https://pedraresearch.org/2021/04/17/series-emerging-mechanisms-of-action-in-the-treatment-of-moderate-to-severe-alopecia-areata-in-children/ (Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Alopecia Areata in Children), Dr. Leslie Castelo-Soccio and Dr. Britt Craiglow answer questions submitted by the PeDRA community. They discuss their approaches to steroids, how to talk oral systemics with patients and caregivers, and identify several research priorities for the future. If you’d like to get involved or learn more about the research ideas discussed in this episode, please send an email to info@pedraresearch.org to be connected with PeDRA’s Hair Disorders Focused Study Group. Note to listeners - to answer all the questions that were submitted, this episode is longer than normal and runs about 60 minutes. Coming soon! The final episode in the series will explore the impact of alopecia areata on patients and caregivers through a heartfelt conversation with a family impacted by the disease.
Dr. Colleen Cotton discusses the findings of her most recent collaborative study - Association of Demographic Factors and Infantile Hemangioma Characteristics with Risk of PHACE Syndrome. Learn more about hemangioma patterns that might suggest greater or lower risk for PHACE Syndrome and how to identify a high-risk patient for a full PHACE Syndrome work up. https://download.socio.events/event/ODQwMQ==?token=eyJhbGciOiJIUzI1NiJ9.eyJkYXRhIjp7InR5cGUiOiJQcm9tb1BhZ2UiLCJldmVudF9pZCI6ODQwMSwiYXBwX2lkIjoxNDI0fSwiaXNzIjoiaHR0cHM6Ly9zb2Npby5ldmVudHMiLCJpYXQiOjE2MjYyNTU1NTh9.9Trat9rsWFVdjKn3z9KMHXZyZpG1c6WMUhadK2N2U6E (Watch in the PeDRA Mobile App) https://youtu.be/c308pad1_4E (Watch on YouTube)
In the first podcast episode of https://pedraresearch.org/2021/04/17/series-emerging-mechanisms-of-action-in-the-treatment-of-moderate-to-severe-alopecia-areata-in-children/ (Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Alopecia Areata in Children), Dr. Carolyn Goh shares her views on patient care, how to find the right treatment for each patient, and her own experience growing up with alopecia. Providing personal insights on everything from the stigma of the disease to potential future treatments, Dr. Goh offers a refreshing perspective on difficult conversations with patients and the options available to them for treating, or not treating their hair disorders. Dr. Goh is a dermatologist, and Associate Clinical Professor of Dermatology at David Geffen School of Medicine at UCLA.
Join Dr. Dawn Davis from the Mayo Clinic in this final episode on Systemic Therapies for Moderate-to-Severe AD in children, for a conversation with Wendy Smith-Begolka, MBS from the National Eczema Association and Korey Capozza, MPH from Global Parents for Eczema Research. Together they answer questions and discuss the importance and value of research. www.nationaleczema.org www.parentsforeczemaresearch.com www.pedraresearch.org
Listen to our first Town Hall to hear distinguished faculty in pediatric dermatology and allergy/immunology answer questions about new and emerging treatments and important research issues for moderate-to-severe atopic dermatitis in children. Special guests Dr. Emma Guttman-Yassky and Dr. Eric Simpson. https://my.captivate.fm/www.pedraresearch.org (www.pedraresearch.org)
Join Dr. Dawn Davis from the Mayo Clinic for a conversation with two patient advocates as they discuss the patient experience with new and traditional AD therapies and share thoughts on how patients and providers can best work together. This episode will be paired with a Patient Perspectives Town Hall webinar featuring special guests Wendy Smith Begolka from the National Eczema Association and Korey Capozza from Global Parents for Eczema Research on January 5 at 5:15PM PST. Register at http://www.pedraresearch.org/education (www.pedraresearch.org/education).
This is the first of two podcasts where distinguished faculty in pediatric dermatology and allergy/immunology talk about new and emerging treatments and important research issues for moderate-to-severe atopic dermatitis in children. Listen to this podcast first and then tune in live on December 8 at 5:15 PM PST for a virtual town hall discussion featuring special guests Dr. Emma Guttman-Yassky and Dr. Eric Simpson. www.pedraresearch.org